Skip to main content
eLife logoLink to eLife
. 2022 Feb 3;11:e71846. doi: 10.7554/eLife.71846

Mapping dopaminergic projections in the human brain with resting-state fMRI

Marianne Oldehinkel 1,2,3,, Alberto Llera 1,2, Myrthe Faber 1,2,4, Ismael Huertas 5, Jan K Buitelaar 1,2, Bastiaan R Bloem 6, Andre F Marquand 1,2,7, Rick C Helmich 1,6, Koen V Haak 1,2,, Christian F Beckmann 1,2,8,
Editors: Shella Keilholz9, Michael J Frank10
PMCID: PMC8843090  PMID: 35113016

Abstract

The striatum receives dense dopaminergic projections, making it a key region of the dopaminergic system. Its dysfunction has been implicated in various conditions including Parkinson’s disease (PD) and substance use disorder. However, the investigation of dopamine-specific functioning in humans is problematic as current MRI approaches are unable to differentiate between dopaminergic and other projections. Here, we demonstrate that ‘connectopic mapping’ – a novel approach for characterizing fine-grained, overlapping modes of functional connectivity – can be used to map dopaminergic projections in striatum. We applied connectopic mapping to resting-state functional MRI data of the Human Connectome Project (population cohort; N = 839) and selected the second-order striatal connectivity mode for further analyses. We first validated its specificity to dopaminergic projections by demonstrating a high spatial correlation (r = 0.884) with dopamine transporter availability – a marker of dopaminergic projections – derived from DaT SPECT scans of 209 healthy controls. Next, we obtained the subject-specific second-order modes from 20 controls and 39 PD patients scanned under placebo and under dopamine replacement therapy (L-DOPA), and show that our proposed dopaminergic marker tracks PD diagnosis, symptom severity, and sensitivity to L-DOPA. Finally, across 30 daily alcohol users and 38 daily smokers, we establish strong associations with self-reported alcohol and nicotine use. Our findings provide evidence that the second-order mode of functional connectivity in striatum maps onto dopaminergic projections, tracks inter-individual differences in PD symptom severity and L-DOPA sensitivity, and exhibits strong associations with levels of nicotine and alcohol use, thereby offering a new biomarker for dopamine-related (dys)function in the human brain.

Research organism: Human

Introduction

The brain’s dopamine system plays an important role in a wide range of behavioural and cognitive functions, including movement and reward processing (Joshua et al., 2009; Ruhé et al., 2007). An integral structure of the dopamine system is the striatum, which receives dense dopaminergic projections from the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) in the midbrain (Steiner and Tseng, 2016). Work in experimental animals has shown that these projections organize along a gradient: dopaminergic neurons in the SNc project preferentially to dorsal caudate and putamen in dorsolateral striatum, while dopaminergic neurons in the VTA project predominantly to the nucleus accumbens (NAcc) in ventromedial striatum (Steiner and Tseng, 2016; Haber, 2014; Björklund and Dunnett, 2007). The projections from the SNc to dorsolateral striatum comprise the nigrostriatal pathway implicated in, for example, the organization of motor planning (Joshua et al., 2009; Faure et al., 2005). The mesolimbic pathway formed by the projections from the VTA to the NAcc has been associated with reward processing (Schultz, 2013; Wise, 2004). In accordance with the partial neuroanatomical overlap in striatum, increasing evidence also suggests partial overlap in the function of both pathways (Haber et al., 2000; Everitt and Robbins, 2005; Wise, 2009). Of note, dopaminergic neurons in the VTA not only project to NAcc but also to prefrontal cortex. These cortical projections form the mesocortical pathway associated with reward-related goal-directed behaviours (Schultz, 2013; Wise, 2004).

In humans, alterations in these dopaminergic projections have been associated with multiple neurological and psychiatric conditions (DeLong and Wichmann, 2007; Money and Stanwood, 2013). A well-known example is Parkinson’s disease (PD), a neurodegenerative disorder characterized by a loss of dopaminergic neurons in the SNc (part of the nigrostriatal pathway; Fearnley and Lees, 1991), which frequently causes asymmetric depletion of dopamine in dorsal striatum (first in putamen, later also to a lesser extent in caudate) and leads to impairments in motor as well as a range of nonmotor functions (Brooks and Piccini, 2006; Hornykiewicz, 2008). Dopaminergic dysfunction has also been implicated in substance use disorder given that addictive substances, such as stimulants, alcohol, and nicotine, increase the release of dopamine in ventral striatum (i.e., mesolimbic pathway; Laruelle et al., 1995; Barrett et al., 2004; Nutt et al., 2015).

Despite the important role of the dopamine system in human brain function and its implication in disease, knowledge about this neurotransmitter system is limited and mainly based on experimental work in animals. The investigation of dopaminergic functioning in vivo in the human brain is challenging, although the nuclear imaging techniques position emission tomography (PET) and single photon emission computed tomography (SPECT) can be used for this purpose (Blake et al., 2003; Volkow et al., 1996). Imaging of the density of the dopamine transporter (DaT) using SPECT has become a popular tool to assist in the differential diagnosis of PD as loss of dopaminergic neurons in PD is accompanied by a loss in DaT in striatum, as opposed to lookalike conditions such as dystonic tremor where the DaT signal remains intact (Brooks, 2016). Tracking the loss of DaT signal over time has also been proposed as a progression biomarker for PD (Brooks, 2016). Indeed, DaT reuptakes dopamine from the synaptic cleft after its release and is highly expressed in the terminals of dopaminergic neurons projecting from the midbrain to striatum (Brooks, 2016). Therefore, DaT SPECT imaging can be used to image dopaminergic projections in striatum. However, the radiation exposure and costs of PET/SPECT combined with the low spatial resolution of the scan limit widespread implementation in human brain research and in clinical practice.

In this work, we hypothesize that inter-individual differences in DaT availability induce inter-individual variations in the synchronicity of functional activity in the brain, and therefore, that dopaminergic projections in the human striatum can also be mapped using blood-oxygen-level-dependent (BOLD) functional MRI (fMRI) measured at rest. We employ a ‘connectopic mapping’ data analysis approach to disentangle striatal connectivity into multiple overlapping spatial ‘modes’ in order to dissect the complex mixture of efferent and afferent connections of the striatum to multiple cortical and subcortical systems (that map onto different neurobiological systems and associated functions; Haak et al., 2018). In previous work, we already showed that the dominant (zeroth-order) mode represents its basic anatomical subdivisions, while the first-order mode maps on to a ventromedial-to-dorsolateral gradient associated with goal-directed behaviour in cortex (Marquand et al., 2017) that has been described previously on the basis of tract-tracing work in non-human primates (Haber and Knutson, 2010). Here, we demonstrate –by conducting a series of analyses across different datasets – that the second-order mode of gradual spatial variations in the BOLD connectivity pattern reflects DaT availability in the striatum. We furthermore reveal that this mode tracks inter-individual differences in symptom severity in PD patients, is sensitive to acute dopaminergic modulation (L-DOPA administration), and exhibits strong associations with levels of nicotine and alcohol use in a population-based cohort. Hereby, we provide compelling evidence that this connectivity mode tracks inter-individual differences in dopaminergic projections, and as such, offers a new biomarker for investigating dopamine-related dysfunction across various neurological and psychiatric disorders.

Results

Striatal connection topographies map onto DaT availability

For our first analysis, we applied connectopic mapping (Haak et al., 2018) to resting-state fMRI data from 839 participants of the Human Connectome Project (HCP; Van Essen et al., 2013). Connectopic mapping extracts the dominant modes of functional connectivity change (or connection topographies) within the striatum based on a Laplacian eigenmap decomposition of the similarity matrix derived from functional connectivity (i.e., Pearson correlations) computed between each striatal voxel and the rest of the brain. It provides reproducible and parsimonious representations of overlapping connection topographies at both the group level and at the level of individual subjects. The connectopic mapping approach is detailed in Materials and methods, but a summary of this procedure can be found in Figure 1.

Figure 1. The connectopic mapping pipeline.

Figure 1.

The functional MRI (fMRI) time-series data from a predefined region of interest (ROI), here the striatum, are rearranged into a time-by-voxels matrix A, as are the time series from all voxels outside the ROI (matrix B). For reasons of computational tractability, the dimensionality of B is losslessly reduced using singular value decomposition (SVD), yielding ∼B. For every voxel within the ROI, its connectivity fingerprint is computed as the Pearson’s correlation (CORR) between the voxel-wise time-series and the SVD-transformed data, yielding matrix C. Then similarity between voxels is computed using the η2 coefficient, resulting in matrix S. Manifold learning using Laplacian eigenmaps is then applied to this matrix, yielding a set of overlapping, but independent, connection topographies or ‘connectivity modes’ that together describe the functional organization of the striatum. These connection topographies indicate how the connectivity profile with the rest of the brain changes across striatum. Voxels that have similar colours in these connectivity modes have similar connectivity patterns with the rest of the brain. Finally, trend surface modelling is applied to summarize the connectivity modes by fitting a set of trend coefficients (β) that optimally combine a set of spatial polynomial basis functions. See Haak et al., 2018 for further details.

For all analyses described in this paper, connectopic mapping was applied to the left and right putamen and caudate-NAcc subregions separately to increase regional specificity and the second-order striatal connectivity mode was selected for each of the four striatal regions of interest (ROIs). A spatial statistical model, that is, a trend surface model (TSM; Gelfand et al., 2010), was fitted to both the group-level and the subject-specific connectivity modes to obtain a small set of coefficients summarizing each of the four striatal modes in the X, Y, and Z axes of MNI152 coordinate space, which we used for statistical analyses. A scree test (Cattell, 1966) indicated that a quadratic model (i.e., consisting of six TSM coefficients) provided the best fit for the second-order connectivity mode in putamen and a quartic model (12 TSM coefficients) was found to provide the best fit for the second-order connectivity mode in caudate-NAcc region.

The subject-specific second-order striatal connectivity modes were highly consistent across the two fMRI sessions (mean ± SD: ρ = 0.98 ± 0.07; averaged across all four subregions) of the HCP dataset, which is in line with what we have demonstrated previously for other brain regions and for the zeroth-order and first-order mode of connectivity in striatum. Furthermore, interclass correlation (ICC(2,k)), which indexes measurement consistency for a putative biomarker (Shrout and Fleiss, 1979; Koo and Li, 2016), showed excellent reproducibility of the subject-specific connectivity modes, while still being sensitive to inter-individual differences (see Table 1). Both the variations across subjects and the reproducibility within subjects are illustrated in Figure 2—figure supplement 3.

Table 1. Interclass correlation coefficients (ICCs) between the two scanning sessions and the session 1 to session 2 within-subject and between-subject spatial correlations.

Striatal subregion ICC[bootstrapped 95% CI] Within-subject correlation Between-subject correlation Within vs. between permutation test(Nperm = 10,000)
Left putamen 0.960 [0.951–0.965] 0.969 0.965 p<0.0001
Right putamen 0.961 [0.952–0.967] 0.970 0.966 p<0.0001
Left caudate-NAcc 0.974 [0.968–0.978] 0.981 0.976 p<0.0001
Right caudate-NAcc 0.974 [0.968–0.978] 0.981 0.977 p<0.0001

CI = confidence interval; NAcc = nucleus accumbens.

The group-level second-order connectivity mode across striatum is displayed in Figure 2 (second row). The modes for left and right putamen and caudate-NAcc have been combined in this figure (i.e., the four ROIs were loaded in FslView simultaneously from which the below figures were derived) to aid in visualization and for later comparison to the DaT SPECT scan. The second-order connectivity mode comprises a gradient from the dorsal putamen and dorsal caudate (shown in red) to the ventral putamen and ventral caudate including the NAcc (shown in blue). This coding indicates that the dorsal putamen and dorsal caudate exhibit a connectivity pattern with the rest of the brain that is similar to each other but different from the ventral putamen and ventral caudate and vice versa. This striatal connectivity pattern might thus correspond with the gradient of mesolimbic and nigrostriatal dopaminergic projections to striatum (ventral vs. dorsal striatum) well described by track-tracing studies in rodents and non-human primates (Steiner and Tseng, 2016; Haber, 2014; Björklund and Dunnett, 2007). We therefore investigated its spatial correspondence to DaT SPECT-derived DaT availability in striatum, which is assumed to be an index of dopaminergic projections. To this end, we averaged across DaT SPECT images obtained from 209 healthy control participants from the Parkinson’s Progression Markers Initiative (PPMI) dataset (Marek et al., 2011). As can be observed in Figure 2, the group-level second-order striatal connectivity mode indeed displays a remarkably high similarity with the group-level DaT availability in striatum, as quantified by a spatial voxel-wise correlation of r = 0.884 (p<0.001), thereby providing the first evidence for an fMRI-derived striatal connectivity marker strongly associated with dopaminergic projections into striatum. A high correlation (r = 0.925, p<0.001) is also present between the orthogonal TSM coefficients modelling the group-level second-order connectivity mode and the group-level DaT SPECT scan across the striatum, providing more evidence that the second-order connectivity mode maps onto dopaminergic projections. This finding does not strongly depend on the chosen model order, given that repeating this analysis using model order 3 (i.e., a cubic model with nine TSM coefficients for both the putamen and caudate-NAcc regions) resulted in a similar correlation (r = 0.90, p<0.0001).

Figure 2. High spatial correspondence between the second-order mode of connectivity in striatum and the DaT SPECT image.

The figure displays the DaT SPECT image averaged across 209 Parkinson’s Progression Markers Initiative (PPMI) controls and the group-level connectivity modes obtained in 839 Human Connectome Project (HCP) subjects. The group-level modes were modelled separately for the left and right putamen and caudate-nucleus accumbens (caudate-NAcc) subregions and have been combined in this figure to aid in visualization. The voxel-wise spatial correlation between the second-order mode of connectivity in striatum and the DaT SPECT image is very high: r = 0.884 (p<0.001). Similarly, the correlation between the orthogonal trend surface model (TSM) coefficients modelling the second-order connectivity mode and the DaT SPECT scan in striatum is very high: r = 0.925 (p<0.001, bottom row). R-fMRI, resting-state fMRI; L, left; R, right.

Figure 2.

Figure 2—figure supplement 1. The correlation between trend surface model (TSM) coefficients modelling the second-order connectivity mode and the DaT SPECT scan is highly significant and substantially higher than all other position emission tomography (PET)-derived markers indexing other neurotransmitter systems.

Figure 2—figure supplement 1.

The top panel displays the absolute, Fisher’s Z normalized correlations between the TSM coefficients modelling the second-order connectivity mode and the TSM coefficients of various SPECT- and PET-derived markers. The dotted lines represent significance values of p=0.01 and p=0.0008 (i.e., p=0.01/12 PET/SPECT scans; Bonferroni-corrected) derived from the null distribution in the bottom panel, which was generated by permuting the TSM coefficients obtained for each of the PET markers (N = 10,000) and computing the absolute (Fisher r-to-z normalized) correlations with the TSM coefficients of the connectivity mode.
Figure 2—figure supplement 2. The second-order connectivity mode obtained in the 10% lowest and 10% highest movers of the Human Connectome Project (HCP) dataset is comparable to the mode obtained in the full sample.

Figure 2—figure supplement 2.

Figure 2—figure supplement 3. Inter-subject and inter-session (within-subject) variability in the second-order mode of connectivity in striatum.

Figure 2—figure supplement 3.

Individual-subject connectivity modes are shown for 10 randomly selected Human Connectome Project (HCP) subjects (from a total of 839). This figure shows variations between subjects as well as variations between sessions for the same subjects.

Finally, to further demonstrate the high specificity of the second-order connectivity mode to the DaT SPECT scan, we computed correlations with the TSM coefficients of all PET scans, tapping into various neurotransmitter systems, included in the publicly available JuSpace toolbox (Dukart et al., 2021). Figure 2—figure supplement 1 reveals that the correlation between the TSM coefficients of the second-order connectivity mode with the DaT SPECT scan is not only highly significant but also significantly higher than the correlations with the TSM coefficients of any other PET scan.

In order to demonstrate that also individual variations in this connectivity mode are associated with individual variations in striatal dopaminergic projections, we further aimed to replicate this mapping at the within-subject level in a subsample of PPMI participants (130 datasets from PD patients and 14 from controls) with both DaT SPECT and resting-state fMRI data available. Within a smaller sample of PD patients and controls with good quality connectivity modes (see Appendix 1—Supplementary analyses and Figure 3—figure supplement 1 for further details), we not only replicated the spatial correspondence between the connectivity mode and DaT SPECT scan at the group level (PD group: r = 0.714; control group: r = 0.721) but also observed a within-subject spatial correlation of 0.58 across the four striatal subregions (0.44> r < 0.62; mean = 0.58, 95% CI = [0.56,0.60]) (see Figure 3). These findings were not induced by residual head motion (see Figure 3—figure supplement 2).

Figure 3. Within-subject correlations between the second-order connectivity mode and the DaT SPECT scan from subjects in the Parkinson’s Progression Markers Initiative (PPMI) cohort where both resting-state functional MRI (fMRI) and DaT SPECT data is available.

These correlations were obtained in a subsample of the PPMI dataset (6–8 datasets from controls and 73–82 datasets from Parkinson’s disease patients depending on the striatal subregion) with good-quality connectivity modes as defined by a high spatial correlation (r > 0.5) with the group-average Human Connectome Project (HCP) connectivity mode. Red dots represent control participants; black dots represent Parkinson’s disease patients.

Figure 3.

Figure 3—figure supplement 1. Spatial correlations of the subject-specific second-order connectivity modes with the mean Human Connectome Project (HCP) connectivity mode and DaT SPECT scan.

Figure 3—figure supplement 1.

These plots show that when the connectivity mode of a subject resembles the HCP group-average connectivity mode – assumed to be an index of good quality – a high spatial similarity can be observed between the connectivity mode and the DaT SPECT scan of that subject. Red dots represent control participants, black dots represent Parkinson’s disease patients.
Figure 3—figure supplement 2. Within-subject correlations between the second-order connectivity mode and the DaT SPECT scan in a low motion and high motion subsample.

Figure 3—figure supplement 2.

These correlations were obtained in a subsample of the Parkinson’s Progression Markers Initiative (PPMI) dataset with good-quality connectivity modes as defined by a high spatial correlation (r > 0.5) with the group-average Human Connectome Project (HCP) connectivity mode. The meanFD cutoff = 0.126, meaning that if the meanFD of a subject was below 0.126 that subject was part of the low motion subsample, if the meanFD was above 0.126, the subject was part of the high motion subsample. Red dots represent control participants; black dots represent Parkinson’s disease patients.

Striatal connection topographies are altered in PD

The strong association of the second-order striatal connectivity pattern with DaT availability suggests that this resting-state fMRI-derived connectivity mode can be used to assess variability (including disease-related alterations) in dopaminergic projections to the striatum. As such, we hypothesized that the second-order connectivity mode would be altered in PD since this disorder is characterized by progressive degeneration of nigrostriatal dopaminergic neurons. In order to validate this hypothesis, we made use of a separate high-resolution PD dataset (Dirkx et al., 2019) including 39 PD patients (19 patients with asymmetric symptoms on the left side of the body, i.e., they were left-dominant; 20 patients were right-dominant) and 20 controls that each underwent two high-resolution resting-state fMRI session (T = 860 ms, 700 time points). Participant characteristics can be found in Table 2. During one session, PD patients received dispersible 200/50 mg levodopa-benserazide (L-DOPA), a precursor of dopamine used for the treatment of PD, during the other session they received placebo (dispersible cellulose). Controls did not receive L-DOPA and placebo but just underwent two typical resting-state fMRI sessions under the same scanning protocol. Thus, this dataset did not only allow us to investigate the effects of clinical diagnosis, but also the effects of acute dopaminergic modulation on the underlying striatal connectivity mode. The associations with diagnosis and L-DOPA were investigated in both groups separately (left-dominant, right-dominant PD) because the side of predominant nigrostriatal dopamine depletion likely influences the pattern of striatal connectivity. As before, the second-order striatal connectivity mode was modelled separately for the putamen and caudate-NAcc subregions to increase regional specificity as PD is known to affect the putamen region of the striatum before the caudate-NAcc region (Kish et al., 1988). Group differences in the TSM coefficients modelling the putamen and caudate-NAcc subregions were subsequently assessed by conducting an omnibus test of all the TSM coefficients, that is, a likelihood ratio test in the context of a logistic regression. We applied correction for multiple comparisons (two groups: left- and right-dominant PD × 2 striatal subregions: putamen and caudate-NAcc) using a Bonferroni-corrected α-level of 0.05/4 = 0.0125. In addition, we also investigated associations between the TSM coefficients and symptom severity across PD patients. To this end, we fitted general linear models (GLMs) that included the TSM coefficients modelling the gradient during the placebo session to predict the total score on the motor section (part III) of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (UPDRS; Goetz et al., 2008). This analysis was again conducted separately for the left- and right-dominant groups and separately for putamen and caudate-NAcc subregions, and a Bonferroni-corrected α-level of 0.0125 was used for establishing statistical significance.

Table 2. Participant characteristics.

Table 2—source data 1. Source data for participant characterists listed in Table 2.
Demographic information(mean, SD) ControlsN = 20 PDN = 39 Test statistic
Age, years 61.9 10.4 60.9 10.7 t(57) = 0.337 NS
Sex, male (number, %) 11 55.0% 16 41.0% X2(1) = 0.086 NS
FAB, total score 17.6 0.67 17.3 0.97 t(57) = 0.23 NS
Disease duration, years NA 3.96 4.57 NA
L-DOPA equivalent at home (mg/day) NA 467.8 227.3 (range: 0–1100) NA
UPDRS total score (mean, SD)
Placebo session NA 40.5 16.4 t(38) = 5.58 p<0.001
L-DOPA session NA 31.9 13.1

For the FAB, lower scores indicate worse functioning; for the UPDRS, higher scores indicate worse functioning. The FAB score was evaluated off medication.

FAB = frontal assessment battery (score 0–18); UPDRS = Unified Parkinson’s Disease Rating Scale part III (score 0–132); NS = not significant; NA = not applicable; PD = Parkinson’s disease; L-DOPA = levodopa-benserazide.

The PD (placebo session) vs. control group analysis (first session) of the TSM coefficients modelling the second-order striatal connectivity mode revealed a significant difference between the right-dominant PD group and the control group in bilateral putamen (but not in the caudate-NAcc region) of the striatum (see Figure 4A; omnibus test of all TSM coefficients: X2 = 27.17, p=0.007). No significant differences were observed between the left-dominant PD group and the control group. Moreover, within the right-dominant patient group, we observed a trend-level association between UPDRS symptom severity scores and the TSM coefficients modelling the putamen under placebo (GLM omnibus test of the TSM coefficients: X2 = 22.28, p=0.035). Post-hoc Pearson correlations revealed that this effect was driven by the quadratic TSM coefficients modelling the striatal connectivity mode in the right putamen in the Y (i.e., anterior-posterior) direction (right Y2: r = 0.476, p=0.034) and Z (i.e., superior-inferior) direction (right Z2: r = −0.460, p=0.041). This association can be observed in Figure 4B, which shows an increase in blue-coded voxels in the second-order striatal connectivity mode as symptom severity increases in PD. This pattern maps very well on the observed decrease in dopaminergic projections as PD becomes clinically more severe, as reflected by higher UPDRS scores. That is, given the spatial similarity of the second-order striatal connectivity mode with the DaT SPECT scan, we can interpret the observed alteration in the connection topography as a decrease in dopaminergic projections to striatum. In Figure 4B, this is evident as an increase in blue-coded voxels and a decrease in red-coded voxels as a function of UPDRS symptom severity. Supplementary analyses showed that the observed group differences and associations with symptom severity were independent of age and sex (Appendix 2—table 1).

Figure 4. The second-order striatal connectivity mode is altered in right-dominant Parkinson’s disease.

Figure 4.

(A) Significant difference between the control group and the right-dominant Parkinson’s disease group under placebo in putamen (omnibus test of all trend surface model [TSM] coefficients for putamen: X2 = 27.17, p=0.007). Images represent the mean connectivity modes across each of the investigated groups. The slices at MNI coordinates x = –26 and x = 26, respectively, show views of the striatal connectivity mode across left and right putamen where the connectivity mode is significantly different between groups (*); the slices at MNI coordinates x = –14 and x = 14, respectively, show views of the mode across left and right caudate-nucleus accumbens (caudate-NAcc) (no significant difference). (B) Trend-level association between the Unified Parkinson’s Disease Rating Scale (UPDRS) symptom severity score and the TSM coefficients modelling the second-order connectivity mode in putamen under placebo across patients in the right-dominant Parkinson’s disease group (general linear model [GLM] omnibus test of all TSM coefficients: X2 = 22.28, p=0.035). Post-hoc Pearson correlations revealed that this effect was driven by the quadratic TSM coefficients modelling the striatal connectivity mode in the right putamen in the Y (i.e., anterior-posterior) direction (right Y2: r = 0.476, p=0.034) and Z (i.e., superior-inferior) direction (right Z2: r = −0.460, p=0.041). The correlation between UPDRS symptom severity scores is displayed for the right Y2 coefficient. To visualize this association, the reconstructed second-order connectivity mode in the right putamen is shown for five Parkinson’s disease patients (data points circled) with increasing UPDRS symptom severity scores.

Striatal connection topographies are sensitive to acute dopaminergic modulation

After demonstrating that the second-order connectivity mode in putamen is indeed altered in PD, we investigated whether it was also sensitive to the acute effects of the dopamine precursor L-DOPA. We assessed differences in this striatal connectivity mode between the placebo and L-DOPA session in both PD groups by conducting an omnibus test of all the TSM coefficients, that is, a likelihood ratio test in the context of a logistic regression. We applied correction for multiple comparisons (two groups: left- and right-dominant PD × 2 striatal subregions: putamen and caudate-NAcc) using a Bonferroni-corrected α-level of 0.05/4 = 0.0125. These tests did not reveal significant differences between the placebo and L-DOPA session in the putamen or the caudate-NAcc region. However, treatment response to L-DOPA is known to differ among PD patients. To take this variability across patients into account, we conducted GLM analyses relating differences in the L-DOPA-induced change (difference between L-DOPA and placebo session) in the second-order striatal connectivity mode to differences in treatment response. These analyses showed that in both patient groups significant associations were present between the L-DOPA-induced change in UPDRS symptom severity scores and the L-DOPA-induced change in TSM coefficients in putamen (GLM omnibus test of all TSM coefficients in the right-dominant patient group: X2 = 25.48, p=0.012; in the left-dominant patient group: X2 = 34.07, p=0.001). Post-hoc Pearson correlations revealed that these effects were driven by the linear TSM coefficient (Y1) modelling the striatal connectivity mode in putamen in the Y (i.e., anterior-posterior) direction (right-dominant PD: left Y1: r = −0.548, p=0.012; left-dominant PD: right Y1: r = 0.345, p=0.15). As can be seen in Figure 5, a larger L-DOPA-induced reduction in UPDRS scores is associated with a larger positive change (i.e., an increase in red-coded voxels) in the superior-anterior part of the putamen, which we hypothesize maps onto an increase in dopamine-related connectivity. Supplementary analyses demonstrated that the observed effects of L-DOPA were independent of age and sex (see Appendix 2—table 1).

Figure 5. Levodopa-benserazide (L-DOPA)-induced reduction in Unified Parkinson’s Disease Rating Scale (UPDRS) symptom severity score is associated with the L-DOPA-induced change in the second-order mode of connectivity in putamen in right-dominant Parkinson’s disease (PD) (general linear model [GLM] omnibus test of all trend surface model [TSM] coefficients modelling putamen: X2 = 25.48, p=0.012).

Figure 5.

Post-hoc Pearson correlations revealed that this effect was driven by the linear TSM coefficient modelling the striatal connectivity mode in the left putamen in the Y direction (left Y1: r = −0.548, p=0.012). To visualize this association, the difference in the reconstructed second-order connectivity modes between the placebo and L-DOPA session is shown for the left putamen (at slice X = –24) for five PD patients (data points circled). Red-coded voxels are hypothesized to map onto an increase in dopaminergic connectivity, blue-coded voxels onto a decrease. A significant effect was also observed for the left-dominant PD group (GLM omnibus test of all TSM coefficients: X2 = 34.07, p=0.001), but as post-hoc Pearson correlations did not reveal significant associations with one of the individual TSM coefficients in this group, this association is not shown. ant, anterior; post, posterior putamen.

Striatal connection topographies are associated with the amount of substance use

Finally, dopaminergic signalling is also implicated in reward processing, alterations of which have been associated with substance use and compulsive behaviours (Laruelle et al., 1995; Barrett et al., 2004; Nutt et al., 2015). As such, we investigated whether the second-order striatal connectivity mode was also associated with tobacco and alcohol use. These quantities are amongst the set of demographic variates available from the HCP. In order to increase specificity and also in order to transcend analysis from a categorical comparison to a continuous characterization predicting the relative amount of substance usage, we consider here a subset of high tobacco and alcohol users. Specifically, we selected otherwise drug-naïve HCP participants who reported to have consumed ≥3 light and/or ≥ 1 heavy alcoholic units per day during the week preceding the scan (N = 30) and participants reporting to have smoked ≥5 cigarettes every day during the week preceding the scan (N = 38). GLM analyses investigating associations between the TSM coefficients modelling the second-order striatal connectivity mode and the amount of use over the past 7 days were conducted separately for the alcohol users and smokers and separately for putamen and caudate-NAcc subregions. We applied correction for multiple comparisons using a Bonferroni-corrected α-level of 0.0125 (see Materials and methods for more details).

In smokers, we observed a significant association with the total number of cigarettes smoked over the past week for the TSM coefficients modelling the second-order connectivity mode in the caudate-NAcc region (X2 = 49.55, p=0.002), but not for the putamen region. Subsequent computation of the Pearson correlations between the individual TSM coefficients and the amount of use revealed that this association was driven by multiple TSM coefficients in both the left and right caudate-NAcc (left X3: r = −0.409, p=0.011; right Z1: r = 0.408, p=0.011; right Y3: r = 0.367, p=0.024; right Z3: r = −0.451, p=0.005; right Y4: r = 0.362, p=0.026; see Figure 6—figure supplement 1). As can be observed in Figure 6 (top panel), alterations in the second-order striatal connectivity mode are subtle but consist of an increase in inferior blue-coded voxels in the caudate-NAcc as tobacco use in this population cohort increases.

Figure 6. The second-order mode of connectivity in striatum is associated with the amount of tobacco use (top) and alcohol use (bottom).

Strong associations were observed between the trend surface model (TSM) coefficients modelling the connectivity mode in the caudate-nucleus accumbens (caudate-NAcc) region and the total amount of tobacco use as well as alcohol use over the past week (general linear model [GLM] omnibus test tobacco use: X2 = 49.55, p=0.002; alcohol use: X2 = 64.45, p<0.001). To visualize these relationships, Pearson correlations between one of the significant TSM coefficients and the amount of use are shown as well as the reconstructed second-order connectivity mode in the right caudate-NAcc (at slice X = 14) for four tobacco users and in the left caudate-NAcc (at slice X = –14) for four alcohol users with increasing of amounts of use (data points circled). Circles and arrows indicate where in the connectivity mode tobacco and alcohol use-related changes can be observed. Correlation plots for the other TSM coefficients can be found in Figure 6—figure supplements 1 and 2.

Figure 6.

Figure 6—figure supplement 1. The second-order mode of connectivity in striatum is associated with the amount of tobacco use.

Figure 6—figure supplement 1.

A strong association was observed between the trend surface model (TSM) coefficients modelling the connectivity mode in the caudate-nucleus accumbens (caudate-NAcc) region and the total amount of tobacco use over the past week (general linear model [GLM] omnibus test: X2 = 49.55, p=0.002). To visualize this relationship, Pearson correlations between the individual TSM coefficients and the amount of use were computed, and the correlations reaching significance (p<0.05) are shown in this figure.
Figure 6—figure supplement 2. The second-order mode of connectivity in striatum is associated with the amount of alcohol use.

Figure 6—figure supplement 2.

A strong association was observed between the trend surface model (TSM) coefficients modelling the connectivity mode in the caudate-nucleus accumbens (caudate-NAcc) region and the total number of alcoholic drinks over the past week (general linear model [GLM] omnibus test: X2 = 64.45, p<0.001). To visualize this relationship, Pearson correlations between the individual TSM coefficients and the amount of use were computed, and the correlations reaching significance (p<0.05) are shown in this figure.

In the ‘heavy’ drinkers, we also observed a strong association with the total number of alcoholic drinks consumed over the past week for the TSM coefficients modelling the connectivity mode in the caudate-NAcc region (X2 = 64.45, p<0.001), but again not for the putamen region. Subsequent computation of the Pearson correlations between the individual TSM coefficients and the amount of use revealed that this association was driven by multiple TSM coefficients in both the left and right caudate-NAcc (left X1: r = −0.378, p=0.039; left Y1: r = 0.399, p=0.029; left Y2: r = 0.488, p=0.006; left Z2: r = −0.386, p=0.035; left X3: r = 0.519, p=0.003; left Y4: r = −0.417, p=0.022; right Z2: r = −0.418, p=0.022; right Z4: r = 0.488, p=0.006; see Figure 6—figure supplement 2). Similar to tobacco use, Figure 6 (bottom panel) shows that higher levels of alcohol use are accompanied by a subtle increase in blue-coded voxels as well as a decrease in red-coded voxels in the caudate-NAcc region of the second-order connectivity mode. We argue that these subtle increases in blue-coded voxels (and decrease in red-coded voxels) in high nicotine and alcohol users map onto decreases in dopaminergic connectivity, which corresponds with reported reductions in dopamine release in striatum in patients with nicotine and alcohol dependence (Nutt et al., 2015; Balfour, 2015). Supplementary analyses revealed that the associations with the amount of tobacco and alcohol use persisted under different usage thresholds and were independent of age and sex (see Appendix 2—tables 1–3). Finally, five subjects were included in both the tobacco and alcohol use analyses, but the associations with tobacco use (X2 = 39.40, p=0.025) and alcohol use (X2 = 62.01, p<0.001) also remained significant after excluding these subjects.

Discussion

In this work, we provide evidence for a resting-state fMRI-derived biomarker of dopamine function in the human striatum. Specifically, we demonstrated that one particular mode of functional connectivity in the striatum showed a high spatial correspondence to DaT availability, a marker of dopaminergic projections derived from DaT SPECT imaging. This observation generated multiple hypotheses that we validated using both data from PD patients and healthy controls. We showed that this second-order striatal connectivity mode is associated with symptom severity and sensitive to acute dopaminergic modulation by L-DOPA in persons with PD, a disorder characterized by a degeneration of dopaminergic neurons projecting to striatum (Fearnley and Lees, 1991; Brooks and Piccini, 2006; Hornykiewicz, 2008). We also demonstrated that this mode is associated with the amount of tobacco and alcohol use, both of which have been related to alterations in dopaminergic signalling (Laruelle et al., 1995; Barrett et al., 2004; Nutt et al., 2015). As such, our results provide evidence that the second-order mode of functional connectivity in striatum maps onto dopaminergic projections and can be used as a non-invasive biomarker for investigating dopaminergic (dys)function in PD and substance use. While our results still need to be replicated out of sample to warrant immediate application in clinical practice, formal quantification of test–retest reliability already suggests that this gradient approach has very high measurement consistency and therefore lends itself for further investigation into the clinical utility across the various neurological and psychiatric disorders associated with dopaminergic functioning.

By applying connectopic mapping, we shift away from the vast majority of resting-state fMRI studies that employ hard parcellations to investigate functional brain connectivity. Gradient-based approaches such as connectopic mapping were only developed recently, but have already been successfully employed in several studies to investigate functional connectivity in cortical (Haak et al., 2018; Margulies et al., 2016; Saadon-Grosman et al., 2020) and subcortical regions (Marquand et al., 2017; Yang et al., 2020; Tian et al., 2020). Recent work (Hong et al., 2020) has furthermore demonstrated that connectivity gradients can generally be obtained with high reproducibility and reliability, and can predict phenotypic variations with higher accuracy than connectivity measures derived from traditional parcellation-based approaches, making them of interest for potential biomarker development. Indeed, hard parcellations only allow investigating the average functional connectivity signal in one or more regions of interest and thereby ignore both the topographic organization of and functional multiplicity in the brain. In contrast, gradient-based approaches do not only enable characterization of smooth, gradual changes in functional connectivity, but also enable the detection of multiple, overlapping modes of functional connectivity in a region that might exist at the same time (Haak and Beckmann, 2020). The work presented here signifies the importance of both features by not only showing that the second-order striatal connectivity mode comprises a smooth gradient from the dorsal putamen and dorsal caudate to the ventral putamen and ventral caudate including the NAcc, but also that this second-order mode – but not the zeroth-order or first-order mode – maps onto DaT availability. In doing so, we are the first to demonstrate a direct mapping between a functional connectivity-derived marker and dopaminergic projections.

DaT is highly expressed in the terminals of dopaminergic neurons projecting from the midbrain to striatum (Brooks, 2016). The high spatial correlation (r = 0.884) between the group-average second-order connectivity mode in the HCP dataset and the group-average DaT SPECT image in the PPMI dataset as well as the significant within-subject spatial correlation between the connectivity mode and DaT SPECT scan (r = 0.58) in PPMI subjects therefore suggests that this connectivity mode maps onto these dopaminergic projections to striatum. We further demonstrated that the association of the second-order connectivity mode with the DaT SPECT scan was stronger than that of all the other investigated PET markers indexing various neurotransmitter systems (see Figure 2—figure supplement 1). This figure also shows that correlations of the second-order connectivity mode with dopamine receptors D1 and D2 in striatum, which are present on postsynaptic dopaminergic neurons, were substantially lower and not significant (r = −0.290, p=0.086 and r = 0.241, p=0.156), suggesting that the second-order connectivity mode is specific to presynaptic dopaminergic projections. Animal work has furthermore shown that dopaminergic projections form a gradient with nigrostriatal neurons from SNc projecting predominantly to the dorsolateral striatum (putamen and caudate) and mesolimbic neurons from the VTA projecting predominantly to the ventromedial striatum (NAcc; Steiner and Tseng, 2016; Haber, 2014; Björklund and Dunnett, 2007) representing a functional connectivity gradient formed by the SNc projections to the dorsolateral (putamen/caudate) and VTA projections to the ventromedial striatum (NAcc). Studies demonstrating that the average striatal DaT binding as obtained by DaT SPECT or PET imaging is highly correlated with averaged post-mortem SN cell counts in humans are in support of this view (Snow et al., 1993; Colloby et al., 2012; Kraemmer et al., 2014). However, to our knowledge the relationship between DaT SPECT/PET and VTA cell counts in humans has not been investigated, and future work will thus be necessary to determine the exact relationship between this striatal connectivity mode, DaT availability assessed by DaT SPECT, and dopaminergic projections.

While we were able to replicate the spatial correlation between the second-order connectivity mode and the DaT SPECT scan at the within-subject level, this spatial correlation (r = 0.58) is not as high as the spatial correlations observed at the group level (i.e., r = 0.721 and r = 0.714 for PPMI controls and PD patients respectively, and r = 0.884 between the DaT SPECT scan in PPMI controls and the connectivity mode in HCP participants). This is not surprising given the relatively low temporal resolution of the resting-state fMRI scan of the PPMI dataset (TR = 2400 ms, 260 volumes). While this resolution is sufficient for typical resting-state fMRI analyses at the group level, the precise delineation of the very fine-grained and overlapping connectivity modes using connectopic mapping at the single-subject level calls for high spatial and temporal resolution data (Haak et al., 2018). However, to our knowledge, there is currently no dataset (publicly) available that includes both a high-resolution resting-state fMRI scan and a DaT SPECT scan from the same participants. With respect to Figure 3, we further note the difference in the within-subject correlation for the putamen (r = 0.61/0.62) compared to caudate-NAcc region (r = 0.51/0.44). We tentatively speculate that this difference might relate to a stronger and more stable dopamine-related resting-state fMRI signal in putamen compared to caudate-NAcc resulting from more dopaminergic projections to putamen (Hörtnagl et al., 2020), and the putamen being larger in size and spatially further away from the ventricles and therefore less susceptible to motion-related artefact than the caudate-NAcc region.

Nevertheless, adding to its association with dopaminergic projections are the alterations of this connectivity mode observed in PD. This disorder is characterized by a loss of nigrostriatal dopaminergic neurons projecting from SNc to the striatum, which is most prominent in the putamen (Fearnley and Lees, 1991). Corresponding to the pathology of the condition, we observed a significant difference of this connectivity mode between right-dominant PD patients and control participants in bilateral putamen. Moreover, within this patient group the second-order striatal connectivity mode was also sensitive to inter-subject variability as revealed by the association with symptom severity. This association is visualized in Figure 4B, which shows that portions of the gradient in right putamen that map on low DaT availability (blue) increase as symptom severity in PD increases. We argue that the second-order striatal connectivity mode hereby follows the expected pattern of a reduction in dopaminergic projections to the putamen (as indexed by decreased DaT availability) as symptom severity increases in PD.

While group differences in the connectivity mode were thus present in bilateral putamen, the association with symptom severity was driven by the TSM coefficients modelling the right putamen. This latter finding might appear counterintuitive as a tremor dominant to the right side of the body in PD (i.e., right-dominant PD) is assumed to correspond with a dopamine depletion that is dominant to the contralateral striatum, that is, left striatum. However, post-mortem studies have reported so-called flooring effects by demonstrating a complete absence of dopaminergic fibres in the dorsal putamen in the most affected hemisphere in PD patients ≥ 4 years after disease onset (Kordower et al., 2013). Furthermore, resting-state fMRI studies have reported larger PD vs. control group differences in the anterior putamen of the lesser affected compared to the more affected hemisphere (Helmich et al., 2010). Taken together, these findings might suggest that in many patients with right-dominant PD in our sample (mean disease duration is 3.96 years) dopamine-related connectivity in the contralateral left putamen is showing flooring effects, making associations with symptoms only detectable in the right putamen. Future research is necessary to confirm this hypothesis. It should also be noted that we did not find a significant difference between controls and the left-dominant PD group. Since there is no evidence that different mechanisms underlie left-dominant and right-dominant PD (apart from the difference in the most-affected hemisphere), this might be a power issue that requires further investigation.

Not only was the second-order mode of connectivity in striatum sensitive to variability in symptom severity in a clinical cohort, but also to behavioural variability associated with self-reported alcohol and tobacco use in a healthy, non-clinical population. Substance use has frequently been associated with alterations in dopamine release in the ventromedial striatum (NAcc), part of the mesolimbic dopaminergic pathway (Laruelle et al., 1995; Barrett et al., 2004; Nutt et al., 2015). Corresponding with these findings, we observed significant associations with the amount of alcohol and tobacco use over the past week in the caudate-NAcc region, but not in the putamen region of the second-order striatal connectivity mode. More specifically, we observed subtle increases in blue-coded voxels and decreases in red-coded voxels as substance use increased, suggesting decreased DaT availability or more generally decreased dopaminergic signalling in the caudate-NAcc region in high nicotine and alcohol users. These results are consistent with findings from previous DaT SPECT and PET studies reporting reductions in striatal DaT availability in patients with alcohol dependence (Grover et al., 2020; Yen et al., 2016; Laine et al., 1999; Repo et al., 1999) and nicotine dependence (Yang et al., 2008). However, a limitation that should be mentioned is that the resting-state fMRI sequence of the HCP dataset has not optimized for subcortical brain regions.

As such, not only are these alterations in PD and high alcohol and tobacco users of the HCP dataset consistent with the hypothesis that the second-order striatal connectivity mode reflects dopaminergic projections, the alterations are also specific to the hypothesized striatal subregions and dopaminergic pathways. That is, we found that PD –a disorder characterized by death of nigrostriatal dopaminergic neurons leading to motor impairments– was associated with connectivity alterations in the putamen, which is a key region of the nigrostriatal pathway that has predominantly been implicated in motor function (Joshua et al., 2009; Faure et al., 2005). On the other hand, tobacco and alcohol use were associated with connectivity alterations in the caudate-NAcc region, which is part of the mesolimbic pathway that has repeatedly been implicated in reward processing and substance use (Schultz, 2013; Wise, 2004).

Finally, we observed that the change in the second-order mode of connectivity in striatum induced by L-DOPA administration was associated with the change in symptom severity in PD patients. L-DOPA is used as a drug for the treatment of PD, yet not all patients are equally responsive to L-DOPA treatment. When L-DOPA crosses the blood–brain barrier, it is converted into dopamine and is assumed to increase dopaminergic signalling (Lewitt, 2008). However, there are differences between PD patients in treatment response, which can be explained by a variety of factors, including differences in the level of systemic L-DOPA uptake from the gut (Nonnekes et al., 2016). Our finding thus indicates that the second-order striatal connectivity mode is differentially sensitive to acute dopaminergic modulation across PD patients and that the amount of this change is associated with the amount of change in symptom severity. This adds to our hypothesis that this mode is associated with dopamine-related functional connectivity and furthermore indicates that studying the dopaminergic system by applying connectopic mapping to resting-state fMRI offers advantages over PET and SPECT scans: PET and SPECT are not only invasive and limited by their low spatial resolution but also depend on indirect measures of dopaminergic signalling such as availability of DaTs and receptors and are therefore not very sensitive to acute, temporal alterations in dopaminergic signalling. In contrast, here we show that connectopic mapping does allow for the investigation of both fine-grained spatial and short-term temporal changes in dopamine-related functional connectivity.

In conclusion, our results provide evidence that the second-order mode of resting-state functional connectivity in striatum is associated with dopaminergic projections and can be developed into a non-invasive biomarker for investigating dopaminergic (dys)function. This may have wide-ranging clinical and scientific applications across disorders associated with dopaminergic functioning. For example, in the diagnostic work-up of movement disorders where DaT SPECT is currently used to distinguish between PD and essential tremor or dystonic tremor, the resting-state fMRI derived second-order connectivity mode might be used instead. The correlation with symptom severity suggests that this mode might also be used as a progression biomarker, for example, to track differences in rate of progression in future intervention studies of new experimental medications aimed at modifying the course of PD. Our results furthermore suggest that this striatal connectivity mode is associated with functions of both the nigrostriatal and mesolimbic pathway, and that it might be possible to differentiate between the two dopaminergic pathways by considering in which striatal subregion that gradient is altered: connectivity alterations seem to occur in putamen for functions associated with the nigrostriatal pathway and in ventral caudate/NAcc for functions associated with the mesolimbic pathway. However, the exact mapping of this striatal connectivity mode on both pathways as well as its relation with the first-order, ventromedial-to-dorsolateral striatal gradient, which we previously linked to goal-directed behaviours, is subject for further investigation.

Materials and methods

Resting-state fMRI data of the HCP dataset

For our first analysis, we used resting-state fMRI data from the HCP, an exceptionally high-quality, publicly available neuroimaging dataset (Van Essen et al., 2013). HCP participants were scanned on a customized 3 T Siemens Skyra scanner (Siemens AG, Erlanger, Germany) and underwent two sessions of two 14.4 min multiband accelerated (TR = 0.72 s) resting-state fMRI scans with an isotropic spatial resolution of 2 mm. Here, we included participants from the S1200 release who completed at least one resting-state fMRI session (2 × 14.4 min) and for whom data was reconstructed with the r227 reconstruction algorithm. (The reconstruction algorithm was upgraded in late April 2013 from the original 177 ICE version to the 227 upgraded ICE version. As the reconstruction version has been shown to make a notable signature on the data that can make a large difference in fMRI data analysis [for details, see https://wiki.humanconnectome.org/display/PublicData/Ramifications+of+Image+Reconstruction+Version+Differences], we only included participants with r227 reconstructions.) This resulted in the inclusion of 839 participants (aged 22–37 years; 458 females). Resting-state fMRI data were preprocessed according to the HCP minimal processing pipeline (Glasser et al., 2013), which included corrections for spatial distortions and head motion, registration to the T1w structural image, resampling to 2 mm MNI152 space, global intensity normalization, and high-pass filtering with a cutoff at 2000s. The data were subsequently denoised using ICA-FIX – an advanced independent component analysis-based artefact removal procedure (Salimi-Khorshidi et al., 2014) – and smoothed with a 6 mm kernel.

Connectopic mapping of the striatum in the HCP dataset

We estimated connection topographies from the HCP resting-state fMRI data using the first session (2 × 14.4 min) for each subject. To this end, we used connectopic mapping (Haak et al., 2018), a novel method that enables the dominant modes of functional connectivity change within the striatum to be traced on the basis of the connectivity between each striatal voxel and the rest of the brain (see Figure 1). In previous work, we showed that the dominant mode (zeroth-order mode) of connectivity in the striatum obtained with connectopic mapping represented its anatomical subdivision into putamen, caudate, and NAcc. Since higher-order modes are restricted by lower-order modes, we decided to take the anatomical subdivision in the striatum into account by applying connectopic mapping in the current work to the left and right putamen and caudate-NAcc striatal subregions separately, thereby also increasing regional specificity. When referring to the second-order mode of connectivity in striatum, we thus refer to the combination of the second-order connectivity modes of putamen and caudate-NAcc. We did not apply connectopic mapping to the NAcc and caudate separately as the left NAcc and right NAcc only include 136 voxels and 127 voxels, respectively. We expect that this very small region is too homogenous in terms of connectivity with cortex to estimate reliable overlapping connectivity modes. Masks for the striatal regions were obtained by thresholding the respective regions from the Harvard-Oxford atlas at 25% probability.

In brief, we rearranged the fMRI time-series data from each striatal subregion and all grey-matter voxels outside the striatum into two time-by-voxels matrices. Since the latter is relatively large, we reduced its dimensionality using a lossless singular value decomposition (SVD). We then computed the correlation between the voxel-wise striatal time-series data and the SVD-transformed data from outside the striatum, and subsequently used the η2 coefficient to quantify the similarities among the voxel-wise fingerprints (Haak et al., 2018). Next, we applied the Laplacian eigenmaps non-linear manifold learning algorithm (Belkin and Niyogi, 2002) to the acquired similarity matrix, which resulted in a set of overlapping, but independent, vectors representing the dominant modes of functional connectivity change across striatum (i.e., connection topographies). Note that this can be done at the group level by using the average of the individual similarity matrices or individually for each subject (as used for statistical analysis). For each subject, modes were aligned to the group-level connectivity mode (by inversion if negatively correlated) to enable visual and statistical comparisons across subjects. We selected the second-order striatal connectivity mode (both the group-average and subject-specific modes) for further analyses.

Finally, to enable statistical analysis over these connection topographies, we fitted spatial statistical models to obtain a small number of coefficients summarizing the second-order connectivity mode of each striatal subregion in the X, Y, and Z axes of MNI152 coordinate space. For this, we use ‘trend surface modelling’ (Gelfand et al., 2010), an approach originally developed in the field of geostatistics, but that has wide-ranging applications due to its ability to model the overall distribution of properties throughout space as a simplified surface. Here, we use the TSM approach to predict each individual subject’s connection topography by fitting a set of polynomial basis functions defined by the coordinates of each striatal location. We fit these models using Bayesian linear regression (Bishop, 2006), where we employed an empirical Bayes approach to set model hyperparameters. Full details are provided elsewhere (Bishop, 2006), but this essentially consists of finding the model hyperparameters (controlling the noise- and the data variance) by maximizing the model evidence or marginal likelihood. This was achieved using conjugate gradient optimization. For fixed hyperparameters, the posterior distribution over the trend coefficients can be computed in closed form. This, in turn, enables predictions for unseen data points to be computed. We used the maximum a posteriori estimate of the weight distribution as an indication of the importance of each trend coefficient in further analyses. To select the degree of the interpolating polynomial basis set, we fit these models across polynomials of degree 2–5 and then compared the different model orders using a scree plot analysis (Cattell, 1966). This criterion strongly favoured a polynomial of degree 2 for the putamen subregion and a polynomial of degree 4 for the caudate-NAcc subregion. This means that the connectivity mode in putamen was modelled with linear and quadratic functions in the X, Y, and Z directions of MNI152 coordinate space (six TSM coefficients) and the connectivity mode in the caudate-NAcc region with linear, quadratic, cubic, and quartic functions in the X, Y, and Z directions of MNI152 coordinate space (12 TSM coefficients). The TSM coefficients of the fitted polynomial basis functions describe the rate at which the connectivity mode changes along a given spatial dimension and can be used for statistical analysis. The polynomials summarized the connectivity modes well, explaining the following mean ± SD of the variance: left putamen: 90.5% ± 4.16%; right putamen: 90.2% ± 4.64%; left caudate-NAcc: 88.6% ± 2.54%; right caudate-NAcc: 89.4% ± 2.15%.

DaT SPECT imaging in the PPMI dataset

To determine whether the second-order striatal connectivity mode was associated with dopaminergic projections in striatum, we investigated its spatial correspondence with DaT availability as revealed by DaT SPECT imaging. We selected DaT SPECT scans for all 210 healthy controls (aged 30–84 years; 71 females) included in the PPMI (Marek et al., 2011) database (https://www.ppmi-info.org/data). PPMI is a public–private partnership funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners (for up-to-date information, please visit https://www.ppmi-info.org/fundingpartners). Each participating PPMI site obtained ethical approval before study initiation, and written informed consent according to the Declaration of Helsinki was obtained from all participants in the study. PPMI scans were obtained at 24 different sites and acquired with a total of seven different SPECT camera models from different manufacturers. All brain images were registered to MNI152 standard space using a linear affine transformation implemented in FSL FLIRT (Jenkinson and Smith, 2001; Jenkinson et al., 2002) and a custom DaT SPECT template (http://www.nitrc.org/projects/spmtemplates; García-Gómez et al., 2013). Typically, analysis of DaT SPECT images is limited to determining the striatal-binding ratio. This index of DaT availability is calculated by normalizing the average DaT uptake in the striatum (or a striatal subregion) by a reference region of minimal DaT availability (e.g., cerebellum or occipital cortex). However, here we were interested in the detailed spatial profile of DaT availability across the striatum. To obtain this spatial profile, we intensity-normalized all raw DaT SPECT images (Llera et al., 2019) so as to optimize contrast in the DaT SPECT image and take into account variability in the DaT SPECT scans across the PPMI dataset as a result of different cameras and different scan sites. Finally, we averaged across all subjects and masked the striatum to obtain the average DaT SPECT image of the striatum.

Mapping the second-order striatal connectivity mode onto DaT availability

Next, we quantified the similarity between the second-order mode of connectivity in striatum and the DaT SPECT image. To this end, we combined the average (i.e., group level) second-order connectivity modes of putamen and caudate-NAcc obtained in the high-resolution HCP dataset and computed the voxel-wise spatial correlation of this mode with the average (i.e., group level) DaT SPECT image of striatum obtained in the PPMI dataset. Given that the voxel-wise spatial correlation between both images might be inflated due to potential spatial autocorrelation effects (i.e., the images represent smooth spatial functions), we additionally computed the correlation between the TSM coefficients modelling the group-average connectivity mode and the group-average DaT SPECT scan since TSM coefficients are orthogonal. More specifically, the TSM coefficients modelling the left and right putamen (2 × 6) and caudate-NAcc regions (2 × 12) were combined and the correlation was computed across all these 36 TSM coefficients. In addition, to show that our results do not heavily depend on the chosen model order, we repeated this analysis using model order 3 (i.e., a cubic model with nine TSM coefficients) for both the putamen and caudate-NAcc regions (i.e., 4 × 9 = 36 TSM coefficients).

For a subsample of PPMI participants with a DaT SPECT scan, there was also a low-resolution resting-state fMRI scan available (130 datasets from PD patients and 14 from controls). We therefore also investigated the within-subject spatial correspondence between the DaT SPECT scan and the second-order connectivity mode for these subjects in the PPMI dataset. This procedure is detailed in Appendix 1—Supplementary analyses.

Resting-state fMRI data of the PD dataset

Given that PD is characterized by a loss of dopaminergic neurons (Fearnley and Lees, 1991), we investigated whether the second-order striatal connectivity mode was altered in PD. For this analysis, we used high-resolution resting-state fMRI data from a cohort consisting of 39 patients with PD (aged 38–81, 23 females) and 20 controls (aged 42–80, 9 females), recruited at the Centre of Expertise for Parkinson & Movement Disorders at the Radboud University Medical Center (Radboudumc) in Nijmegen and scanned at the Donders Institute in Nijmegen, the Netherlands (Dirkx et al., 2019). All patients were diagnosed with idiopathic PD (according to the UK Brain Bank criteria), and all patients had a mild to severe resting tremor besides bradykinesia. In 20 patients, the motor symptoms were right-dominant, in 19 patients left-dominant (dominance here refers to the side of the body displaying the most prominent motor symptoms [including tremor]), which is believed to correspond with a dopamine depletion dominant to contralateral hemisphere in the brain. The study was approved by the local ethics committee, and written informed consent according to the Declaration of Helsinki was obtained from all participants. Detailed sample characteristics can be found in Table 2.

Patients with PD underwent two 10 min resting-state fMRI sessions, that is, a placebo session and L-DOPA session, separated by at least a day on a 3 T Siemens Magnetom Prismafit scanner. Resting-state fMRI scans were obtained with an interleaved high-resolution multiband sequence (TR = 0.860 s, voxel size = 2.2 mm isotropic, TE = 34 ms, flip angle = 20°, 44 axial slices, multiband acceleration factor = 4, volumes = 700). Under both conditions, patients were scanned after overnight fasting in a practically defined off state, that is, more than 12 hr after intake of their last dose of dopaminergic medication. During one session, patients were scanned after administration of L-DOPA, that is, they received a standardized dose of 200/50 mg dispersible levodopa/benserazide. During the other session, patients received placebo (cellulose powder). The cellulose powder and L-DOPA/benserazide were dissolved in water and therefore undistinguishable (visually and olfactory) for the participants as confirmed by a pilot study. Patients also received 10 mg domperidone to improve gastrointestinal absorption of levodopa and reduce side effects. The order of sessions was counterbalanced and the resting-state fMRI scan started on average 48 min (range: 25–70 min) after taking L-DOPA or placebo. Symptom severity was assessed during both sessions with part III (assessment of motor function by a clinician) of the Movement Disorder Society UPDRS (Goetz et al., 2008), and an electromyogram (EMG) of the hand was recorded to monitor tremor-related activity. In light of ethical considerations, control participants did not receive L-DOPA and placebo, they just underwent two typical resting-state fMRI sessions during which the UPDRS was not administered.

Preprocessing of the resting-state fMRI data included removal of the first five volumes to allow for signal equilibration, primary head motion correction via realignment to the middle volume MCFLIRT (Jenkinson et al., 2002), grand mean scaling, and spatial smoothing with a 6 mm FWHM Gaussian kernel. The preprocessing pipeline was furthermore designed to rigorously correct for potential tremor-induced head motion-related artefacts. To this end, we used ICA-AROMA (Pruim et al., 2015), an advanced ICA-based motion correction procedure to identify and remove secondary head motion-related artefacts with high accuracy while preserving signal of interest (Pruim et al., 2015; Parkes et al., 2018). Next, any remaining motion artefacts were removed from the data by regressing out the EMG parameters in addition to the white matter and CSF signal (Helmich et al., 2012). Finally, the data were temporally filtered with a high-pass filter of 0.01 Hz before being resampled to 2 mm MNI152 space.

Investigating the second-order striatal mode in PD

We applied connectopic mapping to the preprocessed resting-state fMRI data of each session from every participant and selected the second-order connectivity mode for further analyses using the same procedure as in the HCP dataset. The subject-specific second-order striatal connectivity modes for control participants were again consistent across the two fMRI sessions mean ± SD ρ = 0.85 ± 0.11 (individual subregions: left putamen: ρ = 0.78 ± 0.10; right putamen: ρ = 0.82 ± 0.12; left caudate-NAcc: ρ = 0.87 ± 0.14; and right caudate-NAcc: ρ = 0.92 ± 0.08). The polynomials also summarized the connectivity modes well, explaining mean ± SD 78.6% ± 11.8% of the variance across the striatum in controls (individual subregions: left putamen: 67.9% ± 16.2%; right putamen: 65.3% ± 21.2%; left caudate-NAcc: 90.5% ± 4.28%; right caudate-NAcc: 90.8% ± 5.63%), and explaining mean ± SD 78.0% ± 10.5% of the variance across striatum in PD patients under placebo (individual subregions: left putamen: 63.6% ± 19.6%; right putamen: 69.5% ± 13.0%; left caudate-NAcc: 88.5% ± 4.69%; right caudate-NAcc: 90.4% ± 4.58%). While these numbers are lower than observed for the connectivity modes obtained from the HCP dataset – which is not surprising given the exceptionally high quality of the HCP dataset – the reproducibility and explained variance of the TSM coefficients are still substantial.

We conducted four different analyses. All these analyses were conducted separately for the left- and right-dominant PD groups – given that the dopamine depletion is dominant to different hemispheres in these two groups – and separately for the putamen and caudate-NAcc subregions (left + right hemisphere combined) to increase regional specificity as PD is known to affect the putamen region of the striatum before the caudate-NAcc region. In all these analyses, we therefore corrected for multiple comparisons using a Bonferroni-corrected α-level of 0.0125 (0.05/4 (2 patient groups * 2 subregions)).

In our first analysis, we compared the second-order striatal connectivity mode between the control and PD groups. To this end, we conducted omnibus tests comparing the TSM coefficients modelling the second-order striatal gradient of the placebo session in the PD group with the TSM coefficients modelling the striatal gradient of the first session of the control group. More specifically, group differences in the TSM coefficients were assessed by using a likelihood ratio test in the context of a logistic regression. We report the X2 (likelihood test) and corresponding p-value of tests that revealed significant group differences. Second, since PD is a heterogeneous disease, we also conducted an analysis taking this variability into account by investigating associations between the TSM coefficients modelling the second-order striatal gradient and symptom severity in PD patients. To this end, we conducted GLMs that included the TSM coefficients modelling the gradient during the placebo session to predict UPDRS symptom severity scores. For all identified associations with UPDRS symptom severity, we report the X2 (likelihood test) and the corresponding p-values, and post-hoc compute Pearson correlations between UPDRS symptom severity and the individual TSM coefficients to determine which coefficients most strongly contributed to the effect.

Third, we assessed differences in the second-order striatal connectivity mode between the placebo and L-DOPA session in both PD groups. More specifically, session differences in the TSM coefficients were assessed by using a likelihood ratio test in the context of a logistic regression. We report the X2 (likelihood test) and corresponding p-value of tests that revealed significant differences between the placebo and L-DOPA session. Finally, treatment response to L-DOPA is known to differ among patients with PD. To take this variability across patients into account, we also investigated whether the L-DOPA-induced change in the second-order striatal connectivity mode was associated with L-DOPA-induced changes in UPDRS symptom severity. More specifically, we calculated the difference in UPDRS symptom scores and TSM coefficients between the placebo and L-DOPA session and investigated associations within the GLM framework. For all identified associations, we post-hoc computed Pearson correlations between the change in UPDRS symptom severity and the change in individual TSM coefficients to determine which coefficients most strongly contributed to the effect.

Investigating the second-order striatal mode in relation to tobacco and alcohol use

Given that alterations in dopaminergic functioning have also been implicated in substance use, we also investigated the association between the second-order striatal connectivity mode and tobacco use as well as alcohol use across high users within the HCP dataset. To this end, we selected HCP participants testing negative for acute drug and alcohol use but who reported to have consumed ≥3 light and/or ≥1 heavy alcoholic drinks per day over the past week (N = 30), and participants reporting to have smoked ≥5 cigarettes every day over the past week (N = 38). Effects of smoking and drinking were analysed separately, and we again modelled the second-order striatal connectivity mode separately for left and right putamen and left and right caudate-NAcc. We conducted GLMs that included next to the amount of use over the past week (i.e., the total number of alcohol drinks or the total number of times tobacco was smoked), the TSM coefficients modelling the second-order striatal connectivity mode (i.e., the TSM coefficients modelling the putamen or caudate-NAcc). Multiple comparison correction was applied using a Bonferroni-corrected α-level of 0.0125 (2 substances * 2 striatal subregions). For all identified associations with the amount of alcohol use or tobacco use, we report the X2 (likelihood test) and the corresponding p-values and post-hoc compute Pearson correlations between the amount of use and the individual TSM coefficients to determine which coefficients most strongly contributed to the association.

Supplementary analyses

To further demonstrate the high specificity of the second-order connectivity mode to the DaT SPECT scan over and above other PET scans (i.e., other neurotransmitter systems), we computed correlations with the TSM coefficients of all PET scans, tapping into various neurotransmitter systems, included in the publicly available JuSpace toolbox (Dukart et al., 2021). This analysis is described in Appendix 1—Supplementary analyses. We also investigated whether the mapping of the second-order connectivity mode onto DaT SPECT scan was influenced by residual head motion. Furthermore, for the other analyses described above (effects of diagnosis and L-DOPA in the PD dataset and associations with tobacco and alcohol use in the HCP dataset), we conducted post-hoc sensitivity analyses to rule out that the group differences and associations revealed by our analyses were dependent on age and sex. In addition, we investigated whether the associations with the amount of tobacco and alcohol use persisted under different usage thresholds. All these analyses are also described in Appendix 1—Supplementary analyses.

Acknowledgements

We made use of HCP data that were provided by the Human Connectome Project, WU-Minn Consortium (principal investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centres that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Centre for Systems Neuroscience at Washington University. We also used data from the Parkinson’s Progression Markers Initiative (PPMI) database (https://www.ppmi-info.org/data). PPMI – a public–private partnership – is funded by the Michael J Fox Foundation for Parkinson’s Research funding partners Abbvie, Avid Radiopharmaceuticals, Biogen Idec, BioLegend, Bristol- Myers Squibb, Eli Lilly & Co., F Hoffman-La Roche, Ltd., GE Healthcare, Genentech, GlaxoSmithKline, Lundbeck, Merck, MesoScale Discovery, Piramal, Pfizer, Sanofi Genzyme, Servier, Takeda, Teva, and UCB. We further used PET scans available in the JuSpace toolbox: https://github.com/juryxy/JuSpace (Dukart et al., 2021).

Appendix 1

Supplementary analyses

Post-hoc analyses comparing the second-order striatal connectivity mode with PET markers of other neurotransmitter systems

We investigated the spatial correspondence of the second-order connectivity mode to multiple PET markers indexing various neuromodulatory systems. To this end, we made use of various PET scans tapping into different neurotransmitter systems (group-averages of 11–36 controls) implemented in the publicly available JuSpace toolbox (https://github.com/juryxy/JuSpace). The included PET scans for the serotonin system are 5HT1a receptor (5HT1a_WAY), 5HT1b receptor (5HT1b_P943), 5HT2a receptor (5HT2a_ALT), and the serotonin transporter (SERT_DASB and SERT_MADAM). The included PET scans for the dopamine system (other than DaT SPECT) are dopamine type 1 receptor (D1_SCH23390), dopamine type 2 receptor (D2_RACLOPRIDE), and FDOPA (FDOPA_f18). In addition, the following neurotransmitter systems were also included: for GABA the GABAa receptor (GABAa_FLUMAZENIL), for noradrenalin the noradrenalin receptor (NAT_MRB), and for the opiod system the mu opiod receptor (MU_CARFENTANIL).

We applied TSM to each of these PET scans in the striatum (as in the main analysis, the rest of the brain was masked and not included) and computed correlations between TSM coefficients modelling the second-order connectivity mode and the TSM coefficients modelling these PET-derived markers. For each PET scan, the correlations with the TSM coefficients were normalized using the Fisher r-to-z transformation and the absolute correlation was taken. These normalized correlations are visualized in the top panel of Figure 2—figure supplement 1. As can be observed, the correlation of the second-order connectivity mode with the DaT SPECT scan is substantially higher than that of any other PET marker. Though it is noticeable that some of the correlations with the PET markers for the serotonin system (SERT_DASB transporter and 5HT1b receptor) that are also known to have a high density in the striatum are also relatively high. Nevertheless, these markers only reach about half of the correlation value of DaT SPECT. To support the robustness and significance of the correlation of our second-order connectivity mode with the DaT SPECT scan over and above the correlation with the markers of the serotonergic system, we tested the correlation between the TSM coefficients obtained for the second-order connectivity mode and the DaT SPECT scan in striatum for significance using permutation testing (N = 10,000). More specifically, we permuted corresponding TSM coefficients obtained for each of the PET markers and thereby generated a null distribution by computing the absolute (Fisher r-to-z normalized) correlations between the connectivity mode TSM coefficients and the permuted TSM coefficients of the other PET markers. Permutations were conducted separately for each coefficient, not permuting across coefficients to ensure interchangeability under the null assumption of no differentiation across different PET markers.

As can be observed in the bottom panel of Figure 2—figure supplement 1, all permuted correlations are lower than the correlation observed between the DaT SPECT scan and the connectivity mode, indicating that the observed correlation between the connectivity mode and DaT SPECT scan is highly significant and unlikely to be obtained by chance. Furthermore, using this null distribution, we defined the Bonferroni-corrected threshold for significance corresponding to p=0.0008 (i.e., p=0.01/12 PET and SPECT scans), which we added to the top figure displaying the correlations with the other PET tracers. This not only confirms that our results are highly significant, but also that the correlations obtained for the other PET markers, including those of the serotonin system, are not only substantially lower, but also do not pass the threshold for significance based on the null distribution. Of note, the correlation with other markers of the dopamine system, such as the D1 and D2 receptor, as opposed to DaT SPECT is not particularly high. However, this is not surprising since these receptors are present on postsynaptic neurons and are likely representative of postsynaptic dopaminergic projections from striatum to cortex, rather than the presynaptic dopaminergic projections from the midbrain to the striatum reflected by the DaT SPECT scan.

Within-subject correspondence between the second-order striatal connectivity mode and the DaT SPECT scan

In the article, we demonstrated that the second-order striatal connectivity mode at the group level (obtained by averaging this mode across all 839 HCP subjects) showed a very high spatial correlation (r = 0.884) with the group-level DaT SPECT image of striatum (obtained by averaging the DaT SPECT images across all 209 PPMI controls). We also aimed to demonstrate that this mapping can be replicated at the within-subject level by investigating the within-subject spatial correspondence between this connectivity mode and the DaT SPECT scan acquired in the PPMI dataset. However, while the PPMI dataset has resting-state fMRI data available for a small subsample of its participants (14 controls with one resting-state fMRI dataset each and 82 PD patients with 130 resting-state fMRI datasets combined; in case of multiple assessments per subject they were separated by at least 1 year), it is of a relatively low temporal and spatial resolution (TR = 2400 ms, 210 time points, 3.3 mm isotropic resolution) compared to the HCP data (TR = 720 ms, 2,400 time points, 2.0 mm isotropic resolution). While this resolution is sufficient for typical resting-state fMRI analyses, the precise delineation of the very fine-grained and overlapping connectivity modes using connectopic mapping calls for high-resolution data. The single-subject connectivity modes in the PPMI dataset (as opposed to the HCP single-subject modes and group-level modes) might therefore not be of sufficient quality and reliable for every subject. To address this issue, we first computed the spatial correlation of each subject’s individual connectivity mode with that of the group-average HCP connectivity mode as well as with the DaT SPECT scan of each subject (see Figure 3—figure supplement 1). In this analysis, the second-order striatal connectivity mode was modelled separately (and correlations were calculated separately) for the left and right putamen and caudate-NAcc subregions. This revealed highly significant positive correlations (0.68 > r < 0.91, all p<4.0e21) across both controls and patients, suggesting that if the connectivity mode of a subject resembles the HCP group-average connectivity mode – assumed to be an index of good quality – a high spatial similarity can be observed between the connectivity mode and the DaT SPECT scan of that subject. Next, we selected those subjects with good-quality connectivity modes as determined by a spatial correlation of r > 0.5 with the group-average connectivity mode in the HCP dataset. Within this sample of 73–86 datasets from PD patients and 6–8 datasets from controls (dependent on the striatal subregion), we not only replicated the spatial correspondence between the connectivity mode and DaT SPECT scan at the group level (patients: r = 0.714; control group: r = 0.721) but also observed significant within-subject spatial correlations (0.44 > r < 0.63; mean = 0.58, 95% CI = [0.56,0.60]) between the connectivity mode and DaT SPECT scan (see Figure 3). While we were able to replicate the spatial correlation between the second connectivity mode and the DaT SPECT scan at the within-subject level, this correlation (r = 0.58) is not as high as the spatial correlations observed in the group level (i.e., r = 0.721 and r = 0.714 for PPMI controls and PD patients, respectively, and r = 0.884 between the DaT SPECT scan in PPMI controls and the connectivity mode in HCP participants). This is, however, not surprising given the relatively low temporal and spatial resolution of the resting-state fMRI scan of the PPMI dataset. However, to our knowledge, there is currently no dataset available that includes both a high-resolution resting-state fMRI scan and a DaT SPECT scan from the same participants.

Post-hoc analyses of head motion

To demonstrate that the mapping of the group-average second-order connectivity mode onto the group-average DaT SPECT scan (r = 0.884) was not influenced by residual head motion, we generated connectivity modes for the 10% highest movers (N = 84, meanFD range: 0.0376–0.0538) and 10% lowest movers (N = 84, meanFD range: 0.1354–0.3155) of the HCP dataset and computed the spatial correlation to the group-average DaT SPECT scan (N = 209, no head motion metrics were available, so we used the entire sample). This analysis revealed very similar connectivity modes (see Figure 3—figure supplement 2) and a very similar spatial correlation for the low FD group (r = 0.883) and the high FD group (r = 0.886), indicating that this mapping was not induced by residual head motion.

Next, we aimed to demonstrate that the mapping between the connectivity mode and the DaT SPECT scan at the within-subject level was also not influenced by residual head motion. To this end, we divided the subsample of the PPMI dataset where both a resting-state fMRI scan and DaT SPECT are available (used for mapping the second-order connectivity mode onto the DaT SPECT at the within-subject level) in half based on the meanFD (meanFD cutoff = 0.126) and computed the within-subject correlation between the DaT SPECT and connectivity mode for the ‘low motion’ and ‘high motion’ halves of the sample separately. This analysis revealed that the within-subject spatial correlation between the DaT SPECT and second-order connectivity mode was virtually identical between the low and high meanFD samples (see Figure 3—figure supplement 2). Although it does appear that for the caudate-NAcc region the correlations between the connectivity mode and the DaT SPECT scan are slightly lower for the high motion half than for the low motion half. This indicates that the high spatial correlation between the connectivity mode with the DaT SPECT scan is not artificially induced by head motion, but that residual head motion instead weakens this correlation. All these additional analyses thus suggest that the proposed biomarker is not picking up on residual motion.

Post-hoc analyses of age and sex

For all the analyses described in the article (effects of diagnosis and L-DOPA in the PD dataset and associations with smoking and drinking in the HCP dataset), we conducted post-hoc sensitivity analyses to rule out that the group differences and behavioural associations revealed by our analyses were dependent on age and sex. To this end, we conducted two types of analyses. First, we repeated our main analyses by including covariates for age and sex in our statistical models in addition to the TSM coefficients to verify that effects remained (close to) significant when including these demographic variables. Next, we only included age and sex in our statistical models (without the TSM coefficients) to verify that effects were not explained by age and/or sex only. The outcomes of these analyses (X2 and p-value) are listed in Appendix 2—table 1 and demonstrate that none of the significant effects observed in our main analyses were dependent on age or sex. However, adding age and sex (age in particular) did increase the significance of findings substantially for the analyses investigating the L-DOPA-induced changes. This might be explained by the fact that patients who are older often have more severe PD and do not benefit as much anymore from L-DOPA treatment.

Post-hoc analyses using different usage thresholds for tobacco and alcohol use

We also investigated whether the associations of the second-order mode of connectivity in striatum with the amount of tobacco use and alcohol use persisted under different usage thresholds. For both tobacco and alcohol use, we chose a daily usage threshold lower (≥2× tobacco/≥1× alcoholic drink) and a daily usage threshold higher (≥8× tobacco/≥3× alcoholic drink) than the one used in the main analysis (≥5× tobacco/≥3× light alcoholic and/or ≥1× hard liquor drinks a day). Please note that the aim of these analyses is not necessarily to show that effects remain significant as under different usage thresholds the sample size and statistical power will change, but rather that the explained variance remains high. Nevertheless, apart from the low-usage threshold for alcohol use, all effects also remained significant, as can be observed in Appendix 2—table 2 and Appendix 2—table 3, indicating that the associations with tobacco and alcohol use were not specific to the chosen usage threshold. However, a pattern that is visible is that associations become stronger when only including the highest users in this population-based sample in the analysis.

Appendix 2

Supplementary tables

Appendix 2—table 1. Post-hoc analyses of age and sex.

Original analysis Original analysis +age and sex Age and sex only
X 2 p-Value X2 p-Value X 2 p-Value
Putamen
Patients vs. controlsRight tremor-dominant Parkinson’s disease 27.17 0.007 27.21 0.018 0.48 0.786
UPDRS symptom severityRight tremor-dominant Parkinson’s disease 22.28 0.035 23.46 0.053 2.38 0.305
L-DOPA-placebo differenceLeft tremor-dominant Parkinson’s disease 34.07 0.001 46.14 <0.001 2.42 0.299
L-DOPA-placebo differenceRight tremor-dominant Parkinson’s disease 25.48 0.012 37.53 0.001 7.18 0.028
Caudate-NAcc
Tobacco useHCP dataset 49.55 0.002 53.56 0.001 1.04 0.594
Alcohol useHCP dataset 64.45 <0.001 174.87 <0.001 9.26 0.010

UPDRS = Unified Parkinson’s Disease Rating Scale; L-DOPA = levodopa-benserazide; HCP = Human Connectome Project; NAcc = nucleus accumbens.

Appendix 2—table 2. Post-hoc analyses using different thresholds for tobacco use.

Original analysis:≥5× tobacco use a dayN = 38 ≥2× tobacco use a dayN = 62 ≥8× tobacco use a dayN = 30
X 2 p-Value X 2 p-Value X 2 p-Value
Tobacco useHCP dataset caudate-NAcc 49.55 0.002 37.96 0.035 70.54 <0.001

HCP = Human Connectome Project; NAcc = nucleus accumbens.

Appendix 2—table 3. Post-hoc analyses using different thresholds for alcohol use.

Original analysis:≥3× light alcoholic and/or ≥1× hard liquor drinks a dayN = 30 ≥1× alcoholic drinks a day (light and/or hard liquor)N = 103 ≥3× alcoholic drinks a day (light and/or hard liquor) *N = 26
X 2 p-Value X 2 p-Value X 2 p-Value
Alcohol useHCP dataset caudate-NAcc 64.45 <0.001 29.94 0.187 196.57 <0.001

HCP = Human Connectome Project; NAcc = nucleus accumbens.

Appendix 2—table 4. Subject IDs from the 839 HCP subjects used in the connectopic mapping analysis.

100206 129129 155635 181636 212823 385450 580044 784565
100610 129331 155938 182032 213017 386250 580347 788674
101006 129533 156031 182436 213421 387959 580650 789373
101107 129634 156435 183034 213522 389357 580751 792766
101309 129937 156536 183337 214524 391748 581450 792867
101410 130114 157437 183741 214625 392447 583858 793465
101915 130316 157942 185341 214726 392750 585256 800941
102008 130417 158136 185442 217126 393247 587664 802844
102109 130619 158338 185846 219231 393550 588565 803240
102311 130720 158843 185947 220721 394956 589567 804646
102513 130821 159138 186040 221218 395251 590047 809252
102614 131217 159340 186141 223929 395756 592455 810439
102715 131419 159441 186545 227432 395958 594156 810843
103010 131722 159744 186848 227533 397154 597869 812746
103111 131823 159845 187143 228434 397861 599065 814548
103212 132017 159946 187345 231928 406432 599469 814649
104012 132118 160729 187547 233326 406836 599671 815247
104416 133019 160830 187850 236130 412528 601127 816653
104820 134021 160931 188145 237334 413934 604537 818455
105014 134223 161630 188347 238033 419239 609143 818859
105620 134425 161832 188448 239136 421226 611938 820745
105923 134627 162026 188549 248339 422632 613235 822244
106016 134829 162228 188751 250932 424939 613538 825048
106521 135124 162733 189349 255740 432332 615441 825553
106824 135225 162935 189450 256540 436239 615744 825654
107018 135528 163129 191033 257542 436845 616645 826454
107220 135629 163331 191235 257845 441939 617748 827052
107321 135730 163836 191336 257946 445543 618952 828862
107422 136126 164030 191841 263436 449753 620434 832651
107725 136227 164131 191942 268749 453441 622236 833148
108020 136631 164636 192035 268850 453542 623137 833249
108121 136732 164939 192136 270332 454140 623844 835657
108222 137027 165032 192237 274542 456346 626648 837560
108323 137229 165234 192641 275645 459453 627852 837964
108525 137431 165436 192843 280739 461743 633847 841349
108828 137532 165638 193441 280941 463040 634748 843151
109123 137633 165941 193845 281135 467351 635245 844961
109325 137936 166438 194443 283543 468050 644044 845458
109830 138130 166640 194645 285345 473952 645450 849264
110007 138332 167036 194746 285446 475855 647858 849971
111211 138837 167238 194847 286347 479762 654350 852455
111413 139233 167440 195041 286650 480141 654552 856463
112112 139435 168240 195445 287248 481042 656253 856968
112314 139839 168341 195950 289555 481951 657659 867468
112516 140117 168745 196346 290136 486759 660951 869472
112920 140319 168947 196851 295146 492754 662551 870861
113316 140824 169040 196952 297655 495255 663755 871762
113922 140925 169444 197348 298455 497865 664757 872562
114116 141119 169545 197651 299154 500222 667056 873968
114217 141422 169747 198047 299760 506234 668361 877269
114318 141826 169949 198249 300618 510225 671855 878776
114419 142424 170631 198350 300719 510326 673455 878877
114621 143224 170934 198653 303119 512835 675661 880157
114823 143426 171128 198855 303624 513130 677766 882161
115017 144125 171330 199352 304727 513736 679568 884064
115219 144731 171431 199453 305830 516742 679770 886674
115724 144832 171532 200008 308129 517239 680250 888678
115825 144933 171633 200109 308331 518746 680452 891667
116221 145127 171734 200311 309636 519647 683256 894067
116423 145531 172029 200513 310621 519950 686969 894774
116524 145632 172130 200917 311320 520228 687163 898176
116726 145834 172433 201414 314225 521331 689470 901038
117021 146129 172534 201717 316633 522434 690152 901442
117728 146331 172635 201818 316835 523032 692964 902242
117930 146432 172938 202113 317332 524135 693764 905147
118023 146533 173132 202719 318637 525541 694362 907656
118124 146634 173334 203418 320826 529549 695768 908860
118225 146735 173435 203923 321323 529953 698168 910241
118528 146937 173536 204016 322224 531536 700634 910443
118831 147030 173637 204319 325129 536647 701535 911849
119025 147636 173738 204420 329844 540436 706040 912447
119126 147737 173839 204521 330324 541640 707749 917558
119732 148133 173940 204622 333330 545345 715041 919966
120414 148335 174841 205220 334635 547046 715950 922854
120515 148436 175136 206222 339847 548250 720337 923755
120717 148941 175237 206323 341834 549757 724446 926862
121315 149236 175338 206525 342129 550439 725751 927359
121416 149741 175540 206727 346137 552241 727553 929464
121618 149842 175742 206828 346945 553344 727654 930449
121921 150625 176037 206929 348545 555348 728454 933253
122317 150726 176441 207123 349244 555651 729254 942658
122418 150928 176744 207426 350330 555954 731140 947668
122620 151021 176845 208024 352132 557857 734247 952863
122822 151324 177140 208125 352738 558657 735148 953764
123420 151425 177241 208327 353740 558960 737960 955465
123521 151728 177342 208428 355239 559457 742549 957974
123723 151829 177645 208630 356948 561444 744553 958976
123824 151930 178142 209127 358144 561949 748662 962058
123925 152225 178243 209228 360030 562345 749058 965771
124220 152427 178647 209329 361234 562446 751550 966975
124624 152831 178748 209531 361941 565452 753150 970764
124826 153025 178849 209834 362034 566454 757764 971160
125222 153126 178950 210011 365343 567052 759869 972566
125424 153227 179245 210112 366042 567961 760551 973770
126426 153631 179346 210415 368551 568963 763557 978578
126628 153732 179952 211114 368753 569965 765864 979984
127226 153833 180129 211215 376247 571144 766563 983773
127327 153934 180230 211316 377451 571548 769064 987074
127630 154229 180432 211619 378756 572045 770352 989987
127731 154330 180533 211821 378857 573249 771354 990366
127832 154532 180735 211922 379657 573451 773257 991267
128026 154734 180836 212015 380036 576255 774663 992673
128127 154835 180937 212116 381038 578057 779370 993675
128329 154936 181131 212217 381543 578158 782561 996782
128935 155231 181232 212419 382242 579867 783462 788674

HCP = Human Connectome Project.

Appendix 2—table 5. Subject IDs from the 209 PPMI controls with DaT SPECT data used in our analysis.

PPMIsubject ID Image IDDaT SPECT PPMIsubject ID Image IDDaT SPECT PPMIsubject ID Image IDDaT SPECT
3000 323662 3350 339901 3637 388521
3004 341194 3351 339902 3639 388523
3008 341195 3353 339904 3651 339008
3009 341196 3355 341236 3651 355956
3011 341198 3357 339907 3656 339014
3013 341200 3358 339908 3658 339016
3016 341202 3361 339911 3662 355221
3029 388468 3362 339912 3668 388528
3053 341207 3363 338780 3750 388535
3055 341209 3368 339917 3754 360616
3057 341211 3369 339918 3756 360617
3064 341217 3370 339919 3759 363950
3069 341221 3389 388504 3765 363951
3070 341222 3390 388505 3767 388536
3071 341223 3401 340345 3768 363952
3072 341224 3404 340346 3769 360618
3073 341225 3405 340347 3779 453700
3074 341226 3410 340351 3794 388545
3075 341227 3411 340352 3796 388147
3085 388470 3414 340354 3803 355230
3087 388472 3424 340363 3804 354344
3100 341230 3438 340388 3805 354345
3103 341233 3450 340398 3806 354346
3104 339536 3452 339923 3807 355231
3106 340418 3453 339924 3811 360620
3109 340423 3457 339928 3812 355232
3112 340426 3458 339929 3813 355233
3114 340430 3460 341243 3816 363953
3115 340431 3464 341245 3817 388148
3151 341018 3466 339932 3850 337832
3156 341021 3468 339934 3851 337833
3157 341022 3478 360613 3852 337834
3160 341023 3479 363945 3853 337835
3161 341024 3480 388509 3854 337836
3165 341027 3481 388510 3855 337445
3169 341031 3503 340400 3857 337837
3171 341033 3515 340408 3859 337839
3172 341034 3517 341248 3907 388556
3188 388483 3518 339537 3908 363957
3191 388486 3521 339539 3917 388563
3200 341036 3523 339541 3950 341083
3201 341037 3524 339542 3952 341085
3202 341038 3525 339543 3955 388565
3204 341040 3526 339544 3959 355241
3206 341042 3527 339545 3965 388573
3208 341044 3541 355215 3966 388574
3213 341049 3543 363946 3967 388576
3215 341051 3544 388514 3968 388577
3216 341052 3551 339550 3969 388578
3217 341053 3554 339552 4004 339032
3219 341055 3554 358138 4007 339035
3221 341057 3555 339553 4008 339036
3222 341058 3563 339559 4009 339037
3235 388488 3565 339561 4010 339038
3237 388490 3569 339564 4014 389268
3257 341067 3570 339565 4018 339045
3260 341068 3571 389245 4032 388583
3264 341070 3572 338781 4063 355246
3270 341074 3576 338785 4067 388593
3271 341075 3600 338788 4079 388596
3274 341077 3611 338797 4090 343886
3276 341079 3613 338799 4095 354353
3277 388491 3614 338800 4100 360623
3286 388494 3615 338801 4104 363963
3300 339889 3619 339001 4105 388600
3301 339890 3620 339002 4116 388613
3310 339896 3624 341251 4118 388615
3316 342187 3627 342204 4139 388627
3318 342189 3635 388519 4140 388628
3320 342191 3636 388520

PPMI = Parkinson’s Progression Markers Initiative; DaT = dopamine transporter; SPECT = single-photon emission computed tomography.

Appendix 2—table 6. Subject IDs from PD patients and controls with resting-state fMRI data and DaT SPECT data from the PPMI dataset used in our analysis.

PPMI subject ID Image ID DaT SPECT Image ID MRI Diagnosis
3310 339896 369414 Control
3318 342189 374882 Control
3350 339901 515208 Control
3351 339902 508245 Control
3353 339904 515216 Control
3361 339911 581042 Control
3369 339918 544617 Control
3389 388504 367349 Control
3551 339550 548987 Control
3563 339559 548989 Control
3565 339561 560369 Control
3769 360618 362609 Control
4018 339045 365285 Control
4032 388583 367390 Control
3107 419849 378215 PD
3108 419850 378223 PD
3116 418649 366137 PD
3116 419854 417052 PD
3118 418470 362555 PD
3118 446107 430138 PD
3119 418650 382277 PD
3119 446108 430147 PD
3120 418651 374854 PD
3122 419241 382284 PD
3123 418652 382289 PD
3123 449008 440114 PD
3124 418653 387304 PD
3124 449009 440118 PD
3125 418654 387314 PD
3125 449010 440128 PD
3126 418655 397752 PD
3126 449011 440131 PD
3128 419553 395434 PD
3128 504427 466848 PD
3130 360608 355962 PD
3130 419554 417000 PD
3132 436066 423718 PD
3132 504428 498892 PD
3134 388480 369013 PD
3134 436067 436351 PD
3327 389212 362478 PD
3327 486550 412180 PD
3332 388500 378540 PD
3352 418905 372319 PD
3354 418906 372327 PD
3359 419866 397593 PD
3360 419867 393662 PD
3364 419868 393672 PD
3365 419659 397597 PD
3366 419869 397624 PD
3367 419870 393674 PD
3371 418673 365166 PD
3372 436070 369487 PD
3372 446121 420330 PD
3373 418674 387316 PD
3373 449019 440174 PD
3374 418675 393614 PD
3374 446122 430165 PD
3377 418677 393628 PD
3377 449020 440186 PD
3378 418678 387324 PD
3380 418679 393636 PD
3380 468270 449575 PD
3383 355208 351070 PD
3383 419560 415707 PD
3385 360612 353398 PD
3385 436861 415713 PD
3386 388502 369048 PD
3387 389214 357590 PD
3387 436071 417033 PD
3392 388507 372995 PD
3392 442969 436390 PD
3552 418922 378354 PD
3556 418923 372348 PD
3556 504848 482323 PD
3557 504849 482329 PD
3559 418926 372359 PD
3559 504850 491605 PD
3574 419676 414623 PD
3575 419677 581115 PD
3575 418690 365225 PD
3585 449026 440198 PD
3586 468275 449581 PD
3587 468276 449584 PD
3591 388516 373018 PD
3591 504435 491626 PD
3592 388517 373035 PD
3592 442973 436404 PD
3593 388518 369096 PD
3593 436073 430199 PD
3593 504436 507400 PD
3758 418698 374893 PD
3758 419880 402067 PD
3760 418499 362591 PD
3787 419576 412194 PD
3800 389258 393684 PD
3808 419885 402071 PD
3815 419886 581145 PD
3818 446139 440242 PD
3819 419270 395448 PD
3822 419271 382366 PD
3822 449035 440262 PD
3823 419272 395585 PD
3823 449036 440267 PD
3824 419579 395592 PD
3824 468279 449614 PD
3825 419273 393639 PD
3825 504450 549048 PD
3826 419274 395600 PD
3826 468280 449625 PD
3828 419580 395605 PD
3828 468281 449661 PD
3829 419581 395614 PD
3830 419582 412202 PD
3830 495006 468929 PD
3831 419583 402267 PD
3832 419584 412209 PD
3832 495007 468935 PD
3834 419585 415724 PD
3834 504454 473094 PD
3835 436875 415731 PD
3838 436075 423748 PD
3838 504456 515249 PD
3869 436077 415744 PD
3870 363956 395313 PD
3870 486557 415751 PD
4005 419890 397646 PD
4011 418504 402285 PD
4019 418710 362640 PD
4019 446143 417057 PD
4021 419277 430178 PD
4022 418712 365294 PD
4022 446145 417065 PD
4029 468288 468943 PD
4030 363959 356036 PD
4030 419596 415756 PD
4030 495322 468949 PD
4034 388585 367425 PD
4034 436083 423755 PD
4035 388587 369183 PD
4035 436084 423762 PD
4035 504466 475680 PD
4038 388590 367446 PD
4038 436085 430210 PD

PD = Parkinson’s disease; DaT = dopamine transporter; fMRI = functional MRI; SPECT = single-photon emission computed tomography; PPMI = Parkinson’s Progression Markers Initiative.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Marianne Oldehinkel, Email: marianne.oldehinkel@donders.ru.nl.

Shella Keilholz, Emory University and Georgia Institute of Technology, United States.

Michael J Frank, Brown University, United States.

Funding Information

This paper was supported by the following grants:

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi Grant No. 864-12-004 to Christian F Beckmann.

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vici Grant No. 17854 to Christian F Beckmann.

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi Grant No. 016.156.415 to Andre F Marquand.

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni Grant No. 016.171.068 to Koen V Haak.

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek Veni Grant No. 91617077 to Rick Helmich.

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek NWO-CAS Grant No. 012-200-013 to Christian F Beckmann.

  • ZonMw Rubicon Grant No. 452172019 to Marianne Oldehinkel.

  • Dutch Brain Foundation Grant F2013(10–15) to Rick C Helmich.

Additional information

Competing interests

No competing interests declared.

No competing interests declared.

C.F.B. is director and shareholder in SBGneuro Ltd.

Author contributions

Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - original draft, Writing – review and editing.

Conceptualization, Formal analysis, Resources, Writing – review and editing.

Methodology, Writing – review and editing.

Formal analysis, Methodology, Resources, Writing – review and editing.

Writing – review and editing.

Writing – review and editing.

Methodology, Software, Writing – review and editing.

Funding acquisition, Resources, Writing – review and editing.

Formal analysis, Investigation, Methodology, Software, Supervision, Writing – review and editing.

Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review and editing.

Ethics

Clinical trial registration https://www.trialregister.nl/trial/4940.

All participants from whom data was used in this manuscript, provided written informed consent (and consent to publish) according to the declaration of Helsinki. For the HCP dataset ethical approval was given by the Washington University Institutional Review Board (IRB), for the PPMI dataset ethical approval was obtained locally at each of the participating sites, and for our local PD dataset ethical approval was obtained from the local ethical committee (Commissie Mensgebonden Onderzoek MO Arnhem Nijmegen, CMO 2014/014).

Additional files

Transparent reporting form

Data availability

We made use of publicly available data from the Human Connectome Project (HCP) dataset, from publicly available data from the Parkinson Progression Marker Initiative (PPMI) dataset, and from a local PD dataset that was part of a clinical trial. See https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release for access to the HCP data. The subject identifiers from the HCP dataset used in our first analysis can be found in Appendix 2 - Table 4. Please note that the subject identifiers from the subset of HCP subjects included in the nicotine-use and alcohol-use analyses cannot be provided, since the access to information about substance use is restricted. For more information about applying to get access to the HCP restricted data and for the HCP restricted data use terms see: https://www.humanconnectome.org/study/hcp-young-adult/document/wu-minn-hcp-consortium-restricted-data-use-terms. For access to the PPMI dataset, see https://www.ppmi-info.org/access-data-specimens/download-data. The subject identifiers from the PPMI dataset used in our analyses can be found in Appendix 2 - Tables 5 and 6. All derived and anonymized individual data from our local PD dataset are available at the Donders Repository: https://data.donders.ru.nl/. The code used for the connectopic mapping procedure in all three datasets is available at the following Github repository: https://github.com/koenhaak/congrads. In addition, for supplementary analyses, we further used PET scans available in the JuSpace Toolbox: https://github.com/juryxy/JuSpace.

The following previously published datasets were used:

Van Essen DC, Smith SM, Barch DM, Behrens TE, Yacoub E, Ugurbil K. 2013. The WU-Minn human connectome project: an overview. Human Connectome Project. Appendix2-Table4

Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T. 2011. The Parkinson Progression Marker Initiative (PPMI) Parkinson Progression Marker Initiative. Appendix2-Tables-5-6

Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PC, Mehta MA. 2021. JuSpace toolbox. Github. JuSpace

References

  1. Balfour DJ. The role of mesoaccumbens dopamine in nicotine dependence. Current Topics in Behavioral Neurosciences. 2015;24:55–98. doi: 10.1007/978-3-319-13482-6_3. [DOI] [PubMed] [Google Scholar]
  2. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse (New York, N.Y.) 2004;54:65–71. doi: 10.1002/syn.20066. [DOI] [PubMed] [Google Scholar]
  3. Belkin M, Niyogi P. Advances in neural information processing systems. Laplacian eigenmaps and spectral techniques for embedding and clustering; 2002. pp. 7–25. [DOI] [Google Scholar]
  4. Bishop CM. Graphical models. Pattern Recognition and Machine Learning. 2006;4:359–422. [Google Scholar]
  5. Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends in Neurosciences. 2007;30:194–202. doi: 10.1016/j.tins.2007.03.006. [DOI] [PubMed] [Google Scholar]
  6. Blake P, Johnson B, VanMeter JW. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT): Clinical Applications. Journal of Neuro-Ophthalmology. 2003;23:34–41. doi: 10.1097/00041327-200303000-00009. [DOI] [PubMed] [Google Scholar]
  7. Brooks DJ, Piccini P. Imaging in Parkinson’s disease: the role of monoamines in behavior. Biological Psychiatry. 2006;59:908–918. doi: 10.1016/j.biopsych.2005.12.017. [DOI] [PubMed] [Google Scholar]
  8. Brooks DJ. Molecular imaging of dopamine transporters. Ageing Research Reviews. 2016;30:114–121. doi: 10.1016/j.arr.2015.12.009. [DOI] [PubMed] [Google Scholar]
  9. Cattell RB. The Scree Test For The Number Of Factors. Multivariate Behavioral Research. 1966;1:245–276. doi: 10.1207/s15327906mbr0102_10. [DOI] [PubMed] [Google Scholar]
  10. Colloby SJ, McParland S, O’Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer’s disease and Lewy body dementias. Brain. 2012;135:2798–2808. doi: 10.1093/brain/aws211. [DOI] [PubMed] [Google Scholar]
  11. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Archives of Neurology. 2007;64:20–24. doi: 10.1001/archneur.64.1.20. [DOI] [PubMed] [Google Scholar]
  12. Dirkx MF, Zach H, van Nuland A, Bloem BR, Toni I, Helmich RC. Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor. Brain. 2019;142:3144–3157. doi: 10.1093/brain/awz261. [DOI] [PubMed] [Google Scholar]
  13. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, Hesse S, Barthel H, Sabri O, Jech R, Eickhoff SB. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Human Brain Mapping. 2021;42:555–566. doi: 10.1002/hbm.25244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience. 2005;8:1481–1489. doi: 10.1038/nn1579. [DOI] [PubMed] [Google Scholar]
  15. Faure A, Haberland U, Condé F, El Massioui N. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. The Journal of Neuroscience. 2005;25:2771–2780. doi: 10.1523/JNEUROSCI.3894-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain. 1991;114 (Pt 5):2283–2301. doi: 10.1093/brain/114.5.2283. [DOI] [PubMed] [Google Scholar]
  17. García-Gómez FJ, García-Solís D, Luis-Simón FJ, Marín-Oyaga VA, Carrillo F, Mir P, Vázquez-Albertino RJ. Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2013;32:350–356. doi: 10.1016/j.remnie.2013.09.003. [DOI] [PubMed] [Google Scholar]
  18. Gelfand AE, Diggle P, Guttorp P, Fuentes M. Handbook of Spatial Statistics. CRC press; 2010. [DOI] [Google Scholar]
  19. Glasser MF, Sotiropoulos SN, Wilson JA, Coalson TS, Fischl B, Andersson JL, Xu J, Jbabdi S, Webster M, Polimeni JR, Van Essen DC, Jenkinson M, WU-Minn HCP Consortium The minimal preprocessing pipelines for the Human Connectome Project. NeuroImage. 2013;80:105–124. doi: 10.1016/j.neuroimage.2013.04.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders. 2008;23:2129–2170. doi: 10.1002/mds.22340. [DOI] [PubMed] [Google Scholar]
  21. Grover T, Gupta R, Arora G, Bal CS, Ambekar A, Basu Ray S, Vaswani M, Sharma A. Dopamine transporter availability in alcohol and opioid dependent subjects – a 99mTc-TRODAT-1SPECT imaging and genetic association study. Psychiatry Research. 2020;305:111187. doi: 10.1016/j.pscychresns.2020.111187. [DOI] [PubMed] [Google Scholar]
  22. Haak KV, Marquand AF, Beckmann CF. Connectopic mapping with resting-state fMRI. NeuroImage. 2018;170:83–94. doi: 10.1016/j.neuroimage.2017.06.075. [DOI] [PubMed] [Google Scholar]
  23. Haak KV, Beckmann CF. Understanding brain organisation in the face of functional heterogeneity and functional multiplicity. NeuroImage. 2020;220:117061. doi: 10.1016/j.neuroimage.2020.117061. [DOI] [PubMed] [Google Scholar]
  24. Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. The Journal of Neuroscience. 2000;20:2369–2382. doi: 10.1523/JNEUROSCI.20-06-02369.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35:4–26. doi: 10.1038/npp.2009.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Haber SN. The place of dopamine in the cortico-basal ganglia circuit. Neuroscience. 2014;282:248–257. doi: 10.1016/j.neuroscience.2014.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I. Spatial Remapping of Cortico-striatal Connectivity in Parkinson’s Disease. Cerebral Cortex. 2010;20:1175–1186. doi: 10.1093/cercor/bhp178. [DOI] [PubMed] [Google Scholar]
  28. Helmich RC, Bloem BR, Toni I. Motor imagery evokes increased somatosensory activity in Parkinson’s disease patients with tremor. Human Brain Mapping. 2012;33:1763–1779. doi: 10.1002/hbm.21318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hong SJ, Xu T, Nikolaidis A, Smallwood J, Margulies DS, Bernhardt B, Vogelstein J, Milham MP. Toward a connectivity gradient-based framework for reproducible biomarker discovery. NeuroImage. 2020;223:117322. doi: 10.1016/j.neuroimage.2020.117322. [DOI] [PubMed] [Google Scholar]
  30. Hornykiewicz O. Basic research on dopamine in Parkinson’s disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neuro-Degenerative Diseases. 2008;5:114–117. doi: 10.1159/000113678. [DOI] [PubMed] [Google Scholar]
  31. Hörtnagl H, Pifl C, Hörtnagl E, Reiner A, Sperk G. Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain. Journal of Neurochemistry. 2020;152:650–662. doi: 10.1111/jnc.14897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Medical Image Analysis. 2001;5:143–156. doi: 10.1016/s1361-8415(01)00036-6. [DOI] [PubMed] [Google Scholar]
  33. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage. 2002;17:825–841. doi: 10.1016/s1053-8119(02)91132-8. [DOI] [PubMed] [Google Scholar]
  34. Joshua M, Adler A, Bergman H. The dynamics of dopamine in control of motor behavior. Current Opinion in Neurobiology. 2009;19:615–620. doi: 10.1016/j.conb.2009.10.001. [DOI] [PubMed] [Google Scholar]
  35. Kish SJ, Shannak K, Hornykiewicz O. Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson’s Disease. New England Journal of Medicine. 1988;318:876–880. doi: 10.1056/NEJM198804073181402. [DOI] [PubMed] [Google Scholar]
  36. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. Journal of Chiropractic Medicine. 2016;15:155–163. doi: 10.1016/j.jcm.2016.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain : A Journal of Neurology. 2013;136:2419–2431. doi: 10.1093/brain/awt192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kraemmer J, Kovacs GG, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. Movement Disorders. 2014;29:1767–1773. doi: 10.1002/mds.25975. [DOI] [PubMed] [Google Scholar]
  39. Laine TP, Ahonen A, Torniainen P, Heikkilä J, Pyhtinen J, Räsänen P, Niemelä O, Hillbom M. Dopamine transporters increase in human brain after alcohol withdrawal. Molecular Psychiatry. 1999;4:189–191. doi: 10.1038/sj.mp.4000514. [DOI] [PubMed] [Google Scholar]
  40. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF. SPECT imaging of striatal dopamine release after amphetamine challenge. Journal of Nuclear Medicine. 1995;36:1182–1190. [PubMed] [Google Scholar]
  41. Lewitt PA. Levodopa for the treatment of Parkinson’s disease. The New England Journal of Medicine. 2008;359:2468–2476. doi: 10.1056/NEJMct0800326. [DOI] [PubMed] [Google Scholar]
  42. Llera A, Huertas I, Mir P, Beckmann CF. Quantitative Intensity Harmonization of Dopamine Transporter SPECT Images Using Gamma Mixture Models. Molecular Imaging and Biology. 2019;21:339–347. doi: 10.1007/s11307-018-1217-8. [DOI] [PubMed] [Google Scholar]
  43. Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T. The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology. 2011;95:629–635. doi: 10.1016/j.pneurobio.2011.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Margulies DS, Ghosh SS, Goulas A, Falkiewicz M, Huntenburg JM, Langs G, Bezgin G, Eickhoff SB, Castellanos FX, Petrides M, Jefferies E, Smallwood J. Situating the default-mode network along a principal gradient of macroscale cortical organization. PNAS. 2016;113:12574–12579. doi: 10.1073/pnas.1608282113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Marquand AF, Haak KV, Beckmann CF. Functional corticostriatal connection topographies predict goal directed behaviour in humans. Nature Human Behaviour. 2017;1:0146. doi: 10.1038/s41562-017-0146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Money KM, Stanwood GD. Developmental origins of brain disorders: roles for dopamine. Frontiers in Cellular Neuroscience. 2013;7:260. doi: 10.3389/fncel.2013.00260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Nonnekes J, Timmer MHM, de Vries NM, Rascol O, Helmich RC, Bloem BR. Unmasking levodopa resistance in Parkinson’s disease. Movement Disorders. 2016;31:1602–1609. doi: 10.1002/mds.26712. [DOI] [PubMed] [Google Scholar]
  48. Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PRA. The dopamine theory of addiction: 40 years of highs and lows. Nature Reviews. Neuroscience. 2015;16:305–312. doi: 10.1038/nrn3939. [DOI] [PubMed] [Google Scholar]
  49. Parkes L, Fulcher B, Yücel M, Fornito A. An evaluation of the efficacy, reliability, and sensitivity of motion correction strategies for resting-state functional MRI. NeuroImage. 2018;171:415–436. doi: 10.1016/j.neuroimage.2017.12.073. [DOI] [PubMed] [Google Scholar]
  50. Pruim RHR, Mennes M, Buitelaar JK, Beckmann CF. Evaluation of ICA-AROMA and alternative strategies for motion artifact removal in resting state fMRI. NeuroImage. 2015;112:278–287. doi: 10.1016/j.neuroimage.2015.02.063. [DOI] [PubMed] [Google Scholar]
  51. Repo E, Kuikka JT, Bergström KA, Karhu J, Hiltunen J, Tiihonen J. Dopamine transporter and D2-receptor density in late-onset alcoholism. Psychopharmacology. 1999;147:314–318. doi: 10.1007/s002130051173. [DOI] [PubMed] [Google Scholar]
  52. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Molecular Psychiatry. 2007;12:331–359. doi: 10.1038/sj.mp.4001949. [DOI] [PubMed] [Google Scholar]
  53. Saadon-Grosman N, Arzy S, Loewenstein Y. Hierarchical cortical gradients in somatosensory processing. NeuroImage. 2020;222:117257. doi: 10.1016/j.neuroimage.2020.117257. [DOI] [PubMed] [Google Scholar]
  54. Salimi-Khorshidi G, Douaud G, Beckmann CF, Glasser MF, Griffanti L, Smith SM. Automatic denoising of functional MRI data: combining independent component analysis and hierarchical fusion of classifiers. NeuroImage. 2014;90:449–468. doi: 10.1016/j.neuroimage.2013.11.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Schultz W. Updating dopamine reward signals. Current Opinion in Neurobiology. 2013;23:229–238. doi: 10.1016/j.conb.2012.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin. 1979;86:420–428. doi: 10.1037//0033-2909.86.2.420. [DOI] [PubMed] [Google Scholar]
  57. Snow BJ, Tooyama I, McGeer EG, Yamada T, Calne DB, Takahashi H, Kimura H. Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels. Annals of Neurology. 1993;34:324–330. doi: 10.1002/ana.410340304. [DOI] [PubMed] [Google Scholar]
  58. Steiner H, Tseng KY. Handbook of Basal Ganglia Structure and Function. Academic Press; 2016. [Google Scholar]
  59. Tian Y, Margulies DS, Breakspear M, Zalesky A. Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nature Neuroscience. 2020;23:1421–1432. doi: 10.1038/s41593-020-00711-6. [DOI] [PubMed] [Google Scholar]
  60. Van Essen DC, Smith SM, Barch DM, Behrens TEJ, Yacoub E, Ugurbil K, WU-Minn HCP Consortium The WU-Minn Human Connectome Project: an overview. NeuroImage. 2013;80:62–79. doi: 10.1016/j.neuroimage.2013.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Volkow ND, Fowler JS, Gatley SJ, Logan J, Wang GJ, Ding YS, Dewey S. PET evaluation of the dopamine system of the human brain. Journal of Nuclear Medicine. 1996;37:1242–1256. [PubMed] [Google Scholar]
  62. Wise RA. Dopamine, learning and motivation. Nature Reviews. Neuroscience. 2004;5:483–494. doi: 10.1038/nrn1406. [DOI] [PubMed] [Google Scholar]
  63. Wise RA. Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends in Neurosciences. 2009;32:517–524. doi: 10.1016/j.tins.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yang YK, Yao WJ, Yeh TL, Lee IH, Chen PS, Lu RB, Chiu NT. Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2008;32:274–279. doi: 10.1016/j.pnpbp.2007.08.018. [DOI] [PubMed] [Google Scholar]
  65. Yang S, Meng Y, Li J, Li B, Fan YS, Chen H, Liao W. The thalamic functional gradient and its relationship to structural basis and cognitive relevance. NeuroImage. 2020;218:116960. doi: 10.1016/j.neuroimage.2020.116960. [DOI] [PubMed] [Google Scholar]
  66. Yen CH, Shih MC, Cheng CY, Ma KH, Lu RB, Huang SY. Incongruent reduction of dopamine transporter availability in different subgroups of alcohol dependence. Medicine. 2016;95:e4048. doi: 10.1097/MD.0000000000004048. [DOI] [PMC free article] [PubMed] [Google Scholar]

Editor's evaluation

Shella Keilholz 1

The authors make a convincing argument that they have found an MRI-based biomarker for dopaminergic input into the striatum. Because the dopaminergic system is involved in neurodegenerative disorders such as Parkinson's disease and also in processing reward signals, the biomarker is likely to become widely adopted and enable new types of experiments in related fields. In this revision, the authors further demonstrate the specificity of the potential biomarker and its lack of sensitivity to head motion.

Decision letter

Editor: Shella Keilholz1
Reviewed by: Shella Keilholz2, Georg Northoff, Finnegan J Calabro3

Our editorial process produces two outputs: (i) public reviews designed to be posted alongside the preprint for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "Mapping dopaminergic projections in the human brain with resting-state fMRI" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, including Shella Keilholz as Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Michael Frank as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Georg Northoff MD, PhD (Reviewer #2); Finnegan J Calabro (Reviewer #3).

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

1) A key assertion of the manuscript is that the biomarker is specific to the dopaminergic system. This assertion needs stronger support. Studies that show that the biomarker disambiguates between different neuromodulatory systems (e.g., serotonergic) are needed to address this issue. For example, existing data could be examined by putting the seed in the subcortical regions like Raphe nucleus and VTA/SN and then investigating their upstream functional connectivity (see Martino et al., 2020, Conio et al., 2020, and others). The results could be compared to the present DA-driven results including conjunction and exclusive masking.

2) Common confounds for resting state fMRI analysis (e.g., head motion) need to be better addressed in terms of how they affect the mode that serves as a biomarker. It is essential to be certain that the biomarker is not picking up motion differences between groups.

Reviewer #1 (Recommendations for the authors):

It was not clear to me how the modes for different parts of the striatum were combined. A brief explanation would be useful.

Have the authors looked at functional connectivity between areas that exhibit differences in the 2nd mode and their hypothesized targets? For example, if the area that exhibits differences as a function of alcohol use also show differences in functional connectivity to a target area that replicates previous studies, it would further strengthen the manuscript.

It would be informative to see if other modes are altered in PD. If they are not, it would suggest great specificity for the 2nd mode.

There’s an interesting difference between the overall correlation of DaT and the 2nd order mode in the putamen as compared to the caudate that should be discussed.

Any overlap between the tobacco and alcohol use group should be described.

Reviewer #2 (Recommendations for the authors):

– The connectopic mapping is based on functional connectivity and correlating time series. May be analysis of dynamic functional connectivity could enhance the validity of the data: if cortical regions show similar dynamic pattern int heir variability, it could be used to further specify the specificity of the cortical connectivity pattern of the striatum.

– May be a figure of the differential cortical connectivity patterns of the three modes (zero-first-, and second-order) (Figure 1) could be shown as that would reveal the cortical specificity of the striatal subregions which is biochemically relevant…

– As I understand the DaT SPECT subjects are different from the HCP subjects so you correlate different healthy subjects with each other…correct? If so, I would recommend at least some healthy subjects to have both SPECT and fMRI (beyond the PD subjects)…..even if a low number, it would increase the validity of the marker….this is important given that, as far as I can see in the tables, there is considerable inter-subject variability in the striatal data both SPECT and fMRI.

– Figure 3: where are the cortical connections in the three fMRI striatal modes? Do they correlate with the DaT SPECT striatal data?

– Also: the HCP sequences and scanning measures are not ideal to capture subcortical regions like the striatum including their subregions as they do not, as far as I recall, contain axial slices….. this could be mentioned as limitation…

– Statistically: the main results on this paper rely on correlation mostly Pearson. It would be nice to have that further solidified by using more robust regression analyses….

Reviewer #3 (Recommendations for the authors):

It is unclear to me how the topographic maps shown in Figure 1 are derived, and specifically how these relate to the spatial fits being performed separately for each region. I would have expected discontinuities in these maps at the regional boundaries, but the maps appear to vary continuously across the striatum, so some clarification on what these maps are representing relative to the per-ROI statistical surface odelling being performed would be helpful.

The resulting second order mode seems qualitatively similar to maps found in previous connectivity mapping approaches (e.g., Tziortzi et al., 2014). Some discussion about either consistency with previous approaches, or description of differences in what this method identifies, would be helpful. In particular, if the patterns are sufficiently similar, this would open the possibility of associating analyses performed using these other atlases for interpretations related to DA distribution. If there are differences, it would be interesting to discuss how these methods differ in the patterns they identify.

I’m confused by the description of a “lossless” SVD for dimensionality reduction (l 543). Presumably to attain a reduction in the matrix size, some proportion of eigenvalues are retained with the rest removed, rendering it lossy. Some clarification here, or information about what proportion is retained, would be helpful.

What is the rationale for using a scree test to choose the best TSM, rather than a less subjective AIC/BIC or similar? The selection of such complex models, in relatively small spatial regions (e.g., quartic model for caudate-Nacc) raises questions about how effectively extra coefficients are being penalized in this approach.

A citation is needed for this assertion: “as PD is known to affect the putamen region of the striatum before the caudate-Nacc region” (l. 215)

eLife. 2022 Feb 3;11:e71846. doi: 10.7554/eLife.71846.sa2

Author response


Essential revisions:

1) A key assertion of the manuscript is that the biomarker is specific to the dopaminergic system. This assertion needs stronger support. Studies that show that the biomarker disambiguates between different neuromodulatory systems (e.g., serotonergic) are needed to address this issue. For example, existing data could be examined by putting the seed in the subcortical regions like Raphe nucleus and VTA/SN and then investigating their upstream functional connectivity (see Martino et al., 2020, Conio et al., 2020, and others). The results could be compared to the present DA-driven results including conjunction and exclusive masking.

We thank the reviewers and editor for this suggestion and agree that providing additional support for the specificity of our potential biomarker to the dopaminergic system would strengthen our results. However, the “typical” seed-based connectivity analyses that are proposed reflect the “average” functional connectivity of one region with another region in the brain, and by using such a seed-based approach there may still multiple (neurotransmitter) systems involved due to mesoscopic nature of connectivity within each relatively large voxel. As such, we decided to directly look at the level of neuromodulatory systems by investigating the neuroreceptor/neurotransporter architecture obtained with PET. More specifically, to be able to demonstrate that the association of the second-order striatal connectivity mode with the DaT SPECT scan is stronger than that of any other neurotransmitter system, we investigated the spatial correspondence of the second-order connectivity mode to a large set of PET markers indexing various neuromodulatory systems. To this end, we made use of various PET scans tapping into different neurotransmitter systems (group-averages of 11-36 controls) obtained from the publicly available JuSpace toolbox (Dukart et al., 2021; https://github.com/juryxy/ JuSpace). The included PET scans for the serotonin system are: 5HT1a receptor (5HT1a_WAY), 5HT1b receptor (5HT1b_P943), 5HT2a receptor (5HT2a_ALT), and the serotonin transporter (SERT_DASB and SERT_MADAM). The included PET scans for the dopamine system (other than DaT SPECT) are: Dopamine type 1 receptor (D1_SCH23390), Dopamine type 2 receptor (D2_RACLOPRIDE), and FDOPA (FDOPA_f18). In addition, the following neurotransmitter systems were also included: for GABA the GABAA receptor (GABAA_FLUMAZENIL), for Noradrenalin the Noradrenalin receptor (NAT_MRB) and for the opiod system the mu opiod receptor (MU_CARFENTANIL).

We applied trend surface modelling (TSM) to each of these PET scans in the striatum (as in the original submission the rest of the brain was masked and not included) and computed correlations between TSM coefficients modelling the second-order connectivity mode and the TSM coefficients modelling these PET-derived markers. For each PET scan, the correlations with the TSM coefficients were normalized using the Fisher r-to-z transformation and the absolute correlation was taken. These normalized correlations are visualized in Figure 2—figure supplement 1 of the revised manuscript. As can be observed, the correlation of the second-order connectivity mode with the DaT SPECT scan is substantially higher than that of any other PET marker. Though it is noticeable that some of the correlations with the PET markers for the serotonin system (SERT_DASB transporter and 5HT1b receptor) that are also known to have a high density in the striatum, are also relatively high. Nevertheless these markers only reach about half of the correlation value of DaT SPECT. To support the robustness and significance of the correlation of our second-order connectivity mode with the DaT SPECT scan over and above the correlation with the markers of the serotonergic system, we tested the correlation between the TSM coefficients obtained for the second-order connectivity mode and the DaT SPECT scan in striatum for significance using permutation testing (N=10000). More specifically, we permuted corresponding TSM coefficients obtained for each of the PET markers and thereby generated a null distribution by computing the absolute (Fisher r-to-z normalized) correlations between the connectivity mode TSM coefficients and the permuted TSM coefficients of the other PET markers. Permutations were conducted separately for each coefficient, not permuting across coefficients to ensure interchangability under the null assumption of no differentiation across different PET markers.

As can be observed in the bottom figure, all permuted correlations are lower than the correlation observed between the DaT SPECT scan and the connectivity mode, indicating that the observed correlation between the connectivity mode and DaT SPECT scan is highly significant and unlikely to be obtained by chance. Furthermore, using this null distribution, we defined the Bonferoni-corrected threshold for significance corresponding to p=0.0008 (i.e., p=0.01/12 PET and SPECT scans), which we added to the top figure displaying the correlations with the other PET tracers from the Juspace toolbox. Of note, the correlation with the dopaminergic D1 and D2 receptors, as opposed to DaT SPECT is not particularly high. However, this is not surprising since these receptors are present on postsynaptic neurons and are likely representative of postsynaptic dopaminergic projections from striatum to cortex, rather than the presynaptic dopaminergic projections from the midbrain to the striatum reflected by the DaT SPECT scan.

We have included the above description and figure (Figure 2—figure supplement 1) in the Supplementary Materials. In addition, we have also added the following sections to the results and Discussion sections of our manuscript:

Results, page 6 (lines 163-168):

“Finally, to further demonstrate the high specificity of the second-order connectivity mode to the DaT SPECT scan, we computed correlations with the TSM coefficients of all PET scans, tapping into various neurotransmitter systems, included in the publicly available JuSpace toolbox (Dukart et al., 2021). Figure 2—figure supplement 1 reveals that the correlation between the TSM coefficients of the second-order connectivity mode with the DaT SPECT scan is not only highly significant but also significantly higher than the correlations with the TSM coefficients of any other PET scan.”

Discussion, pages 12 (lines 353-359):

“We further demonstrated that the association of the second-order striatal connectivity mode with the DaT SPECT scan is stronger than that of all the other investigated PET markers indexing various neurotransmitter systems, see Figure 2—figure supplement 1. This figure also shows that correlations of the second-order connectivity mode with dopamine receptors D1 and D2 in striatum, which are present on postsynaptic dopaminergic neurons, were substantially lower and not significant (r=-0.290, p=0.086 and r=0.241, p=0.156), suggesting that the second-order connectivity mode is specific to presynaptic dopaminergic projections.”

2) Common confounds for resting state fMRI analysis (e.g., head motion) need to be better addressed in terms of how they affect the mode that serves as a biomarker. It is essential to be certain that the biomarker is not picking up motion differences between groups.

We agree with the reviewers that head motion can have a profound impact on resting-state functional connectivity analyses if not properly controlled for. However, we would first like to point out that the amount of head motion in all the samples we investigated was rather low to start with and very comparable between the different samples, see Author response table 1. Furthermore, the resting-state data of the HCP dataset was thoroughly corrected for head-motion related artifacts by applying ICA-FIX (Salimi-Khorshidi et al., 2014). Similarly, in the PPMI dataset and in our local PD dataset we thoroughly correct for head motion-related artifacts using ICA-AROMA (Pruim et al., 2015), which has been demonstrated to remove head motion-related artifacts with high accuracy while preserving signal of interest (Parkes et al., 2017). In our local PD dataset we moreover removed any residual head-motion artefacts from the data by regressing out the EMG parameters used for monitoring potential tremor-related activity. Nevertheless and in order to rule out that our findings are related to residual head motion, we conducted two additional post-hoc sensitivity analyses, which are also described below, both for the group level findings and the within-subject associations.

Author response table 1.

meanFD
N Mean SD Range
HCP 839 0.0871 0.0362 0.0375-0.3155
PPMI all DaT SPECT controls 209 Not available for DaT SPECT scan
PPMI within-subject analysis, full sample 144 0.1308 0.0620 0.0438-0.3124
PPMI within-subject analysis, patients 130 0.1292 0.0609 0.0438-0.3124
PPMI within-subject analysis, controls 14 0.1463 0.0541 0.0722-0.2778
Local PD dataset, full sample placebo 59 0.1104 0.0535 0.0352-0.2762
Local PD dataset, patients placebo 39 0.1165 0.0492 0.0490-0.2363
Local PD dataset, controls placebo 20 0.0987 0.0604 0.0352-0.2762
Local PD dataset, patients LDOPA 39 0.1277 0.0825 0.0376-0.5252*
*There was 1 subject with a meanFD of 0.5252, but also after excluding this subject results remained significant. All other subjects had a meanFD<0.3.

Sensitivity analysis: group-level mapping connectivity mode onto DaT SPECT

To demonstrate that the mapping of the group-average second order connectivity mode onto the group-average DaT SPECT scan (r=0.884) was not influenced by residual head motion, we generated connectivity modes for the 10% highest movers (N=84, meanFD range: 0.0376-0.0538) and 10% lowest movers (N=84, meanFD range: 0.1354-0.3155) of the HCP dataset and computed the spatial correlation to the group-average DaT SPECT scan (N=209, no head motion metrics available, so we used the entire sample). This analysis revealed very similar connectivity modes, see Figure 2—figure supplement 2 of the revised manuscript and a very similar spatial correlation for the low FD group (r=0.883) and the high FD group (r=0.886), indicating that this mapping was not induced by residual head motion.

Sensitivity analysis: within-subject mapping connectivity mode and DaT SPECT

We divided the subsample of the PPMI dataset where both a resting-state fMRI scan and DaT SPECT (used for mapping the second-order connectivity mode onto the DaT SPECT at the within-subject level) is available in half based on the median of the meanFD (meanFD = 0.126) and computed the within-subject correlation between the DaT SPECT and connectivity mode for the ‘low motion’ and ‘high motion’ halfs of the sample separately. This analysis revealed that the within-subject spatial correlation between the DaT SPECT and second-order connectivity mode was virtually identical between the relatively low and relatively high meanFD sample, now included as Figure 3—figure supplement 2 of the revised manuscript. It does appear that for the caudate-NAcc region the correlations between the connectivity mode and the DaT SPECT scan are slightly lower for the relatively high motion group than for the relatively low motion group. This indicates that the high spatial correlation of the connectivity mode with the DaT SPECT scan is not artificially induced by head motion, but that residual head motion instead weakens this correlation (i.e. it ads noise leading to an underestimation of the true spatial correspondence). All these additional analyses thus suggest that the proposed biomarker is not picking up on residual motion.

These additional analyses are now described in the “Post-hoc analyses of residual head motion” paragraph of appendix 1 and the results are shown in Figure 2—figure supplement 2 and Figure 3—figure supplement 2.

Reviewer #1 (Recommendations for the authors):

It was not clear to me how the modes for different parts of the striatum were combined. A brief explanation would be useful.

We apologize for the opacity. All analyses in this paper were conducted for each striatal ROI separately, but in Figures 1 and 2 the four striatal modes have been combined purely for visualization purposes. This was achieved by loading the striatal modes simultaneously in FslView from which the figures were derived. This was possible because the four striatal ROIs did not spatially overlap and were each normalized to have values (indicating variations in connectivity profiles) ranging from 0 to 1.

We have adjusted the following sections on pages 4 and 5 of the manuscript to clarify this procedure:

Lines 118-120: “For all analyses described in this paper, connectopic mapping was applied to the left and right putamen and caudate-NAcc subregions separately to increase regional specificity and the second-order striatal connectivity mode was selected for each of the four striatal ROIs.”

Lines 140-141: “The modes for left and right putamen and caudate-NAcc have been combined in this figure (i.e., the four ROIs were loaded in FslView simultaneously from which the below figures were derived) to aid …”

Have the authors looked at functional connectivity between areas that exhibit differences in the 2nd mode and their hypothesized targets? For example, if the area that exhibits differences as a function of alcohol use also show differences in functional connectivity to a target area that replicates previous studies, it would further strengthen the manuscript.

In this paper, we hypothesized that the mapping between the second-order connectivity mode and the DaT SPECT scan reflects dopaminergic projections from the midbrain (SN and VTA) to the striatum. In theory we could investigate connectivity between the midbrain and striatum. However, we do not know how our connectivity mode relates to cortical connectivity, which we assume the reviewer is referring to. Due to methodological constraints, it is unfortunately extremely difficult, if not impossible, to obtain and investigate functional connectivity specific to the second-order mode. That is, functional connectivity between two regions represents the synchronicity between the ‘average’ BOLD signal in region A and the ‘average’ BOLD signal in region B. One key feature of our novel analysis approach, however, is that our connectivity modes are ‘overlapping’ in the striatum. While this addresses the functional multiplicity across ROIs it suffers from the fact that the only way to obtain the cortical connectivity patterns, i.e., targets, specific to one particular connectivity mode would be to do a regression analysis in which we correct for the other connectivity modes. This has previously been shown to not be useful because a lot of signal is removed/regressed out. Accordingly, it is difficult to empirically investigate the unique (cortical) projections of only the second-order connectivity mode. The approach proposed is further limited by the fact that connectivity modes are defined to index a gradient, reflecting a gradual change in the connectivity pattern. These gradients by definition are not associated with a single projection but instead reflect a spectrum of projections. Such a view on functional connectivity is very unique and we therefore cannot think of any existing study using more classical (non-overlapping, non-gradual) characterizations that we can replicate in this fashion. For more information please see our 2020 review paper in Neuroimage on interpreting functional connectivity results in the face of functional heterogeneity and multiplicity (Haak and Beckmann 2020).

It would be informative to see if other modes are altered in PD. If they are not, it would suggest great specificity for the 2nd mode.

We have previously related the first-order striatal connectivity mode to cortico-striatal projections (Marquand et al., 2017) and prior work in PD has consistently shown that cortico-striatal connectivity is altered in PD (for reviews see Filippi et al., 2019, Movement disorders; Tessitore et al., 2019, Journal of Parkinson’s Disease). Such studies have found that connectivity of the (posterior) putamen with (motor) cortex is decreased in PD patients compared to controls, which is thought to be secondary effect related to the degeneration of dopaminergic neurons in the putamen. Consistent with these findings, when we conduct our analyses for the first-order connectivity mode this also revealed a significant difference for the putamen region between the control group and right-dominant PD group (Χ2=33.342, p=0.015), as well as a significant difference between the control group and left-dominant PD group (Χ2=54.040, p<0.001). Since the first-order connectivity maps onto cortico-striatal connectivity, alterations in connectivity of putamen are likely reflected in this connectivity mode. While an absence of a significant difference for the first-order connectivity mode of course would have suggested greater specificity for the second order mode, the fact that the first-order mode is also different in PD, is not surprising.

There's an interesting difference between the overall correlation of DaT and the 2nd order mode in the putamen as compared to the caudate that should be discussed.

While the mean within-subject correlation of DaT and the second-order mode across the four striatal subregions is 0.58, the reviewer has correctly noticed that this correlation is higher in left and right putamen (r=0.61/0.62) than in the left and right caudate region (0.51/0.44; see Figure 3). We speculate that this difference might relate to three potential factors:

1) The putamen contains higher levels of dopamine than the caudate-NAcc (Hortnagl et al., 2020) which could be the result of more dopaminergic projections to the putamen and the putamen might therefore also be more strongly associated with dopamine-related signaling than the caudate-NAcc.

2) The putamen has more voxels (N=2171) than caudate-NAcc (N=1678) (in MNI152 2mm space) and therefore the resting-state fMRI signal in putamen is likely more stable than signal in caudate-NAcc.

3) The caudate-NAcc lies directly next to the ventricles, resulting in a high-intensity border (CSF vs gray matter) on the MRI scan, whereas putamen lies a bit further away from the ventricles. As such, (small amounts of) head motion of the participant will disturb the signal of the caudate-NAcc more than for putamen.

We have added the following section to the discussion (page 13, lines 380-386) of the manuscript:

“With respect to Figure 3, we further note the difference in the within-subject correlation for the putamen (r=0.61/0.62) compared to caudate-NAcc region (r=0.51/0.44). We tentatively speculate that this difference might relate to a stronger and more stable dopamine-related resting-state fMRI signal in putamen compared to caudate-NAcc resulting from more dopaminergic projections to putamen (Hortnagl et al., 2020), and the putamen being larger in size and spatially further away from the ventricles and therefore less susceptible to motion-related artefact than the caudate-NAcc region.”

Any overlap between the tobacco and alcohol use group should be described.

A total of 5 subjects were included in both the tobacco use and alcohol use analyses. We post-hoc excluded these participants and repeated both analyses, which showed that both the association with alcohol use (Χ2=39.40, p=0.025) and with tobacco use (Χ2=62.01, p<0.001) were still significant. This means that our results were stable and thus not driven by the excluded, overlapping participants. We have added the following sentence to the manuscript (page 10, lines 308-310):

“Finally, five subjects were included in both the tobacco and alcohol use analyses but the associations with tobacco use (Χ2=39.40, p=0.025) and alcohol use (Χ2=62.01, p<0.001) also remained significant after excluding these subjects.”

Reviewer #2 (Recommendations for the authors):

– The connectopic mapping is based on functional connectivity and correlating time series. May be analysis of dynamic functional connectivity could enhance the validity of the data: if cortical regions show similar dynamic pattern int heir variability, it could be used to further specify the specificity of the cortical connectivity pattern of the striatum.

We agree with the reviewer that an analysis of dynamical functional connectivity of the striatum is very interesting and indeed we are currently adapting the connectopic mapping methodology to look into dynamically changing connectivity gradients. This work remains to be validated and therefore we believe such an analysis would be beyond the scope of this paper. Given that none of the data sets used in our current manuscript features an intervention during the course of the data acquisition, however, we belief that our future methodological advances (and indeed even other types of ‘dynamic functional connectivity’) would be hard to interpret, let alone validate. As such, for this data these approaches are unlikely to enhance the validity of our results since the striatal connectivity modes are defined based on their functional connectivity profile with the rest of the brain, including the cortex.

– May be a figure of the differential cortical connectivity patterns of the three modes (zero-first-, and second-order) (Figure 1) could be shown as that would reveal the cortical specificity of the striatal subregions which is biochemically relevant…

We recognize that showing the differential connectivity patterns of the three different striatal connectivity modes would be very informative. Yet, as already mentioned in response to the second comment of reviewer 1, due to methodological constraints it is unfortunately extremely difficult, if not impossible, to obtain and visualize these connectivity patterns for each specific striatal connectivity mode. That is, functional connectivity between two regions represents the synchronicity between the ‘average’ BOLD signal in region A and the ‘average’ BOLD signal in region B. One key feature of our novel analysis approach, however, is that our connectivity modes are ‘overlapping’ in the striatum. While this addresses the functional multiplicity across ROIs, it suffers from the fact that the only way to obtain the cortical connectivity patterns specific to one particular connectivity mode would be to do a regression analysis in which we correct for the other connectivity modes. Indeed, we conducted such analyses for striatum and anterior temporal lobe in Marquand et al., 2017 and a later preprint (https://www.biorxiv.org/content/10.1101/2020.05.28.121137v1) and showed that while this regression approach works reasonable well for obtaining the cortical projections for the primary, dominant gradient, it leads to very noisy estimates for higher order gradients, where the dominant gradient needs to be regressed. Accordingly, it is difficult to empirically investigate the unique (cortical) projections of each specific connectivity mode. The approach proposed is further limited by the fact that connectivity modes are defined to index a gradient, reflecting a gradual change in the connectivity pattern. These gradients by definition are not associated with a single projection but instead reflect a spectrum of projections.

Therefore, rather than rely on cortical projections to address the specificity of the findings, in our response to comment 1 in the essential revisions section we actually demonstrated biochemical specificity of the second-order mode to the DaT SPECT scan. We investigated the spatial correspondence of the second-order connectivity mode with multiple PET markers indexing various neuromodulatory systems and showed that the mapping of the second-order connectivity mode to the DaT SPECT scan was not only highly significant but also superior to all investigated markers (e.g., neurotransmitter-specific receptors and transporters) of other neurotransmitter systems.

– As I understand the DaT SPECT subjects are different from the HCP subjects so you correlate different healthy subjects with each other…correct? If so, I would recommend at least some healthy subjects to have both SPECT and fMRI (beyond the PD subjects)…..even if a low number, it would increase the validity of the marker….this is important given that, as far as I can see in the tables, there is considerable inter-subject variability in the striatal data both SPECT and fMRI.

We agree with the reviewer. Next to our initial analysis in which we mapped the group-level second-order connectivity mode obtained in the HCP dataset onto the group-level DaT SPECT obtained in the PPMI dataset, we demonstrate validity of this mapping at the within-subject level in a subsample of PPMI participants (130 datasets from PD patients and 14 from controls) with both a DaT SPECT scan and resting-state fMRI data available (see Figure 3 in the manuscript).

We apologise if it was not clear that these analyses were indeed based on subjects where both SPECT and fMRI data were available – we have now clarified this further in the figure caption. To summarize, within a smaller sample of PD patients and controls with good quality connectivity modes, we not only replicated the spatial correspondence between the connectivity mode and DaT SPECT scan at the group-level in both the PD group (r=0.714) and in the control group (r=0.721) but also observed a within-subject spatial correlation of 0.58 across the four striatal subregions (0.44>r<0.62; mean=0.58, 95% CI = [0.56,0.60]), see Figure 3. This latter analysis included both control (red dots) and PD subjects (black dots), and as can be observed Figure, correlations appear similar in the control group (despite being a very small group) and PD group.

– Figure 3: where are the cortical connections in the three fMRI striatal modes? Do they correlate with the DaT SPECT striatal data?

Figure 3 shows the spatial correlation between the second-order connectivity mode and the DaT SPECT scan for four striatal subregions across a subsample of PPMI controls and patients that had both a resting-state fMRI scan and DaT SPECT scan available. We have clarified this further in the figure caption.

– Also: the HCP sequences and scanning measures are not ideal to capture subcortical regions like the striatum including their subregions as they do not, as far as I recall, contain axial slices….. this could be mentioned as limitation…

The reviewer is correct that the scanning sequences used in the HCP dataset are multiband sequences that have been optimized to acquire signal in cortex and therefore are not ideal for investigating signals within subcortical structures. The reduced temporal signal-to-noise ratio in subcortex, however, has been demonstrated not to matter too much when characterizing average connectivity due to the extreme high N and otherwise exquisite data quality (Smith et al., 2013, Neuroimage: Resting-state fMRI in the Human Connectome Project). Indeed, the fact that we find multiple strong associations with connectivity modes in striatum implies that the signal-to-noise ratio is subcortical areas was still sufficiently high to detect these associations, and furthermore this also means that we likely underestimated the strength of these associations, given that low tSNR will predominantly impact on the sensitivity of the analysis.

We do now mention this as a limitation on page 14, lines 426-428 in the discussion of the manuscript:

“However, a limitation that should be mentioned is that the resting-state fMRI sequence of the HCP dataset has not been optimized for subcortical brain regions.”

– Statistically: the main results on this paper rely on correlation mostly Pearson. It would be nice to have that further solidified by using more robust regression analyses….

Indeed, in order to gain confidence over and above Pearson correlations we already tested all associations with behavior robustly using multiple linear regression analyses that included all the TSM coefficients modeling the second-order connectivity mode (we also refer to these analyses as omnibus tests in the manuscript, as for example in the second paragraph on page 7). In case such a regression analysis revealed a significant association, Pearson correlations with the individual TSM were computed post-hoc to visualize and interpret these relationships.

Reviewer #3 (Recommendations for the authors):

It is unclear to me how the topographic maps shown in Figure 1 are derived, and specifically how these relate to the spatial fits being performed separately for each region. I would have expected discontinuities in these maps at the regional boundaries, but the maps appear to vary continuously across the striatum, so some clarification on what these maps are representing relative to the per-ROI statistical surface modeling being performed would be helpful.

To clarify, the connectivity modes shown in Figure 1 are the same as the modes shown in Figure 2. We indeed applied connectopic mapping to the putamen and caudate-NAcc regions separately to be able to investigate the second-order connectivity mode in these striatal subregions separately. In Marquand et al., 2017, we showed that the zero-order connectivity mode represents the anatomical subdivision of the striatum into putamen, caudate and NAcc. By focusing on the second-order gradient, we thus discount the variance associated with individual subnuclei and therefore we don’t see these strong discontinuities (i.e., the zero-order mode) anymore in the second-order mode, nor when investigating the putamen and caudate-NAcc separately and also not when combining these modes into one figure for visualization.

The resulting second order mode seems qualitatively similar to maps found in previous connectivity mapping approaches (e.g., Tziortzi et al., 2014). Some discussion about either consistency with previous approaches, or description of differences in what this method identifies, would be helpful. In particular, if the patterns are sufficiently similar, this would open the possibility of associating analyses performed using these other atlases for interpretations related to DA distribution. If there are differences, it would be interesting to discuss how these methods differ in the patterns they identify.

To the best of our knowledge there are currently no papers published that obtained and investigated higher-order (functional) connectivity gradients in striatum that can be compared to the second-order gradient obtained in our study. Several papers applying parcellation-based approaches to striatum have been published, yet these do not allow for overlapping (connectivity) modes but are based on the mean, dominant signal in striatum. We believe that to be able to obtain neurotransmitter specific distributions in the brain from structural or functional MRI data, the applied method needs to allow for overlapping connectivity profiles.

Tziortzi et al., (2014) generated a parcellation of the striatum based on structural connectivity with cortical systems derived from diffusion-weighted imaging data. This parcellation does indeed look somewhat similar to our connectivity mode. However, the figure displaying this parcellation (Figure 2) only consists of coronal views of striatum, making it difficult to define the exact spatial correspondence to our second-order striatal connectivity mode. Indeed, when comparing Figure 2 from the Tziortzi paper with the coronal slices for zeroth-order, first-order and second-order mode shown in Figure 2 (middle row, y=6) of our paper, it is difficult to conclude with which of these modes the Tziortzi parcellations show the highest spatial similarity, so we refrain from making comparisons with the Tziortzi paper in our article.

I'm confused by the description of a "lossless" SVD for dimensionality reduction (l 543). Presumably to attain a reduction in the matrix size, some proportion of eigenvalues are retained with the rest removed, rendering it lossy. Some clarification here, or information about what proportion is retained, would be helpful.

The term lossless in the context of an SVD is used to indicate that an SVD is applied where initially all eigenvalues and thus, all data, are being retained. Please note that within our framework we are not using a SVD for dimensionality reduction, but only for defining an orthonormal basis to ease computation.

What is the rationale for using a scree test to choose the best TSM, rather than a less subjective AIC/BIC or similar? The selection of such complex models, in relatively small spatial regions (e.g., quartic model for caudate-NAcc) raises questions about how effectively extra coefficients are being penalized in this approach.

The selection of the most appropriate model order is indeed a bit tricky in this case because of the high smoothness of the connectivity mode, which is inherent to the connectopic mapping procedure enforcing a gradient-like structure. This high smoothness in turn makes it difficult to estimate correct spatial degrees of freedom (DoF), which methods like AIC/BIC use for penalization. We actually have looked at AIC and BIC, but due to the smoothness of the connectivity mode they always picked the highest model order, meaning that these methods do not correctly penalize. Therefore we here used the scree test, which more effectively penalizes in this type of data. In addition, we repeated our analysis using model order 3 (that is a cubic model with 9 TSM coefficients) for both the putamen and caudate-NAcc regions, which gave us similar results: the correlation between the TSM coefficients modeling the second-order connectivity mode and the DaT SPECT scan is r=0.90, p<0.0001, which is comparable to our original finding (r=0.925, p<0.0001). This thus indicates that our findings do not heavily depend on the chosen model order.

We have added the following sections to the manuscript:

Results, page 6, lines 159-162:

“This finding does not heavily depend on the chosen model order, given that repeating this analysis using model order 3 (that is a cubic model with 9 TSM coefficients for both the putamen and caudate-NAcc regions – 4x9 TSM coefficients), resulted in a similar correlation (r=0.90, p<0.0001).”

Methods, page 19, lines 587-589:

“In addition, to show that our results do not heavily depend on the chosen model order, we repeated this analysis using model order 3 (that is a cubic model with 9 TSM coefficients) for both the putamen and caudate-NAcc regions (i.e., 4x9=36 TSM coefficients).”

A citation is needed for this assertion: "as PD is known to affect the putamen region of the striatum before the caudate-NAcc region" (l. 215)

We apologize for the missing reference and have now added Kish et al., 1988, which is of the earliest studies supporting this claim.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Van Essen DC, Smith SM, Barch DM, Behrens TE, Yacoub E, Ugurbil K. 2013. The WU-Minn human connectome project: an overview. Human Connectome Project. Appendix2-Table4 [DOI] [PMC free article] [PubMed]
    2. Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T. 2011. The Parkinson Progression Marker Initiative (PPMI) Parkinson Progression Marker Initiative. Appendix2-Tables-5-6 [DOI] [PMC free article] [PubMed]
    3. Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PC, Mehta MA. 2021. JuSpace toolbox. Github. JuSpace [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Table 2—source data 1. Source data for participant characterists listed in Table 2.
    Transparent reporting form

    Data Availability Statement

    We made use of publicly available data from the Human Connectome Project (HCP) dataset, from publicly available data from the Parkinson Progression Marker Initiative (PPMI) dataset, and from a local PD dataset that was part of a clinical trial. See https://www.humanconnectome.org/study/hcp-young-adult/document/1200-subjects-data-release for access to the HCP data. The subject identifiers from the HCP dataset used in our first analysis can be found in Appendix 2 - Table 4. Please note that the subject identifiers from the subset of HCP subjects included in the nicotine-use and alcohol-use analyses cannot be provided, since the access to information about substance use is restricted. For more information about applying to get access to the HCP restricted data and for the HCP restricted data use terms see: https://www.humanconnectome.org/study/hcp-young-adult/document/wu-minn-hcp-consortium-restricted-data-use-terms. For access to the PPMI dataset, see https://www.ppmi-info.org/access-data-specimens/download-data. The subject identifiers from the PPMI dataset used in our analyses can be found in Appendix 2 - Tables 5 and 6. All derived and anonymized individual data from our local PD dataset are available at the Donders Repository: https://data.donders.ru.nl/. The code used for the connectopic mapping procedure in all three datasets is available at the following Github repository: https://github.com/koenhaak/congrads. In addition, for supplementary analyses, we further used PET scans available in the JuSpace Toolbox: https://github.com/juryxy/JuSpace.

    The following previously published datasets were used:

    Van Essen DC, Smith SM, Barch DM, Behrens TE, Yacoub E, Ugurbil K. 2013. The WU-Minn human connectome project: an overview. Human Connectome Project. Appendix2-Table4

    Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T. 2011. The Parkinson Progression Marker Initiative (PPMI) Parkinson Progression Marker Initiative. Appendix2-Tables-5-6

    Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PC, Mehta MA. 2021. JuSpace toolbox. Github. JuSpace


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES